<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">107813</article-id><article-id pub-id-type="doi">10.7554/eLife.107813</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.107813.3</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>An in vitro human vessel model to study <italic>Neisseria meningitidis</italic> colonization and vascular damages</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Pinon</surname><given-names>Léa</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8645-071X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Chabaud</surname><given-names>Melanie</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3167-7076</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Nivoit</surname><given-names>Pierre</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4893-6348</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Wong Ng</surname><given-names>Jerome</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8287-5203</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Nguyen</surname><given-names>Tri-Tho</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9991-7094</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Paul</surname><given-names>Vanessa</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Bouquerel</surname><given-names>Charlotte</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Goussard</surname><given-names>Sylvie</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Smilovici</surname><given-names>Pauline</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Frachon</surname><given-names>Emmanuel</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Obino</surname><given-names>Dorian</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4108-2714</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Gobaa</surname><given-names>Samy</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0125-8674</contrib-id><email>samy.gobaa@pasteur.fr</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Dumenil</surname><given-names>Guilllaume</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9174-9110</contrib-id><email>guillaume.dumenil@pasteur.fr</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05f82e368</institution-id><institution>Institut Pasteur, Université Paris Cité, INSERM UMR1225, Pathogenesis of vascular infections</institution></institution-wrap><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05f82e368</institution-id><institution>Institut Pasteur, Université Paris Cité, Biomaterials and Microfluidics core facility</institution></institution-wrap><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Miao</surname><given-names>Edward A</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00py81415</institution-id><institution>Duke University</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Kana</surname><given-names>Bavesh D</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03rp50x72</institution-id><institution>University of the Witwatersrand</institution></institution-wrap><country>South Africa</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>17</day><month>12</month><year>2025</year></pub-date><volume>14</volume><elocation-id>RP107813</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2025-06-18"><day>18</day><month>06</month><year>2025</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2025-06-02"><day>02</day><month>06</month><year>2025</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.02.09.579276"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2025-08-29"><day>29</day><month>08</month><year>2025</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.107813.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2025-11-14"><day>14</day><month>11</month><year>2025</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.107813.2"/></event></pub-history><permissions><copyright-statement>© 2025, Pinon et al</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Pinon et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-107813-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-107813-figures-v1.pdf"/><abstract><p>Systemic infections leading to sepsis are life-threatening conditions that remain difficult to treat, and the limitations of current experimental models hamper the development of innovative therapies. Animal models are constrained by species-specific differences, while 2D cell culture systems fail to capture the complex pathophysiology of infection. To overcome these limitations, we developed a laser photoablation-generated, three-dimensional microfluidic model of meningococcal vascular colonization, a human-specific bacterium that causes sepsis and meningitis. Laser photoablation-generated hydrogel engineering allows the reproduction of vascular networks that are major infection target sites, and this model provides the relevant microenvironment reproducing the physiological endothelial integrity and permeability in vitro. By comparing with a human-skin xenograft mouse model, we show that the model system not only replicates in vivo key features of the infection, but also enables quantitative assessment with a higher spatiotemporal resolution of bacterial microcolony growth, endothelial cytoskeleton rearrangement, vascular E-selectin expression, and neutrophil response upon infection. Our device thus provides a robust solution bridging the gap between animal and 2D cellular models, paving the way for a better understanding of disease progression and developing innovative therapeutics.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>sepsis</kwd><kwd>meningitis</kwd><kwd>endothelium</kwd><kwd>microfluidics</kwd><kwd>blood vessel</kwd><kwd>Neisseria</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Other</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04w6kn183</institution-id><institution>Fondation pour la Recherche Médicale</institution></institution-wrap></funding-source><award-id>EQU202203014610</award-id><principal-award-recipient><name><surname>Dumenil</surname><given-names>Guilllaume</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0472cxd90</institution-id><institution>European Research Council</institution></institution-wrap></funding-source><award-id>Destop</award-id><principal-award-recipient><name><surname>Dumenil</surname><given-names>Guilllaume</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution>Fondation NRJ</institution></institution-wrap></funding-source><award-id>Grand prix</award-id><principal-award-recipient><name><surname>Dumenil</surname><given-names>Guilllaume</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00rbzpz17</institution-id><institution>Agence Nationale de la Recherche</institution></institution-wrap></funding-source><award-id>ANR 10-LBX-62 IBEID</award-id><principal-award-recipient><name><surname>Dumenil</surname><given-names>Guilllaume</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00rbzpz17</institution-id><institution>Agence Nationale de la Recherche</institution></institution-wrap></funding-source><award-id>ANR MeningoChip 18-CE15-0006-01</award-id><principal-award-recipient><name><surname>Dumenil</surname><given-names>Guilllaume</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution>Région Ile-de-France</institution></institution-wrap></funding-source><award-id>DIM Elicit</award-id><principal-award-recipient><name><surname>Gobaa</surname><given-names>Samy</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>A vessel on a chip microfluidic device recapitulates the main features of meningococcal vascular colonization, providing high time and space microscopy resolution of the infection process in 3D.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Infectious diseases remain a significant global health burden, underscoring the need for continued advances in diagnosis, prevention, and treatment strategies. Developing novel therapeutic strategies against infections requires a deep understanding of the underlying physiopathological mechanisms and robust experimental models that capture their hallmark features. The lack of models replicating the 3D infection environment while enabling quantitative assessments is slowing the pace of infection research. Overcoming this limitation is thus essential to drive progress in infectious disease research and address the growing challenge of antimicrobial resistance (<xref ref-type="bibr" rid="bib52">Murray et al., 2022</xref>). In this study, we focused on meningococcal disease, which is a model system for systemic infectious diseases that are particularly severe forms of infection. Furthermore, as for most pathogens, meningococcal disease is highly human-specific, thus raising specific challenges for the development of experimental models.</p><p>Clinical studies have provided the key elements of <italic>N. meningitidis</italic> pathogenesis leading to the vascular damages observed during <italic>purpura fulminans</italic>. Histological studies of postmortem samples have shown that bacteria are found primarily inside blood vessels of different organs, including the liver, the brain, the kidneys, and the skin (<xref ref-type="bibr" rid="bib42">Mairey et al., 2006</xref>). Bacteria are typically found associated with the endothelium on the luminal side in tight aggregates (<xref ref-type="bibr" rid="bib46">Melican and Dumenil, 2012</xref>). The infection is associated with signs of vascular function perturbations, including congestion, intravascular coagulation, and loss of vascular integrity (<xref ref-type="bibr" rid="bib23">Faust et al., 2000</xref>). The presence of bacteria within the lumen of blood vessels is also associated with an inflammatory infiltrate, mainly composed of neutrophils and monocytes (<xref ref-type="bibr" rid="bib26">Guarner et al., 2004</xref>). A valid model of meningococcal infection should thus reproduce the interaction of bacteria with the endothelium and immune cells, as well as infection-induced vascular damage.</p><p>To overcome the human-species specificity of meningococcal infections in an animal model, a human skin xenograft mouse model was developed (<xref ref-type="bibr" rid="bib47">Melican et al., 2013</xref>). This model was instrumental in demonstrating the importance of bacterial type IV pili (T4P) for vascular colonization (<xref ref-type="bibr" rid="bib47">Melican et al., 2013</xref>) and neutrophil recruitment in infected venules (<xref ref-type="bibr" rid="bib44">Manriquez et al., 2021</xref>). The neutrophils interacting with the infected human endothelium are of murine origin, adding complexity to the interpretation of these interactions and the resulting immune response. In addition, while providing the proper tissue context for meningococcal infection, this model is dependent on access to human skin, complex surgical procedures, and animal use.</p><p>Another popular experimental approach involves the use of endothelial cells in in vitro culture, where interaction between <italic>N. meningitidis</italic> and single human cells are studied on flat 2D surfaces (<xref ref-type="bibr" rid="bib14">Doulet et al., 2006</xref>; <xref ref-type="bibr" rid="bib4">Bonazzi et al., 2018</xref>; <xref ref-type="bibr" rid="bib12">Denis et al., 2019</xref>; <xref ref-type="bibr" rid="bib1">Alonso-Roman et al., 2024</xref>). Such models have been used to decipher the molecular interplay underlying bacteria-bacteria and bacteria-endothelial cell interactions and have been essential in characterizing the host cell reorganization upon bacterial adhesion (<xref ref-type="bibr" rid="bib48">Merz and So, 1997</xref>; <xref ref-type="bibr" rid="bib6">Charles-Orszag et al., 2018</xref>). This notably includes the remodeling of the plasma membrane with the formation of filopodia-shaped protrusions that stabilize the microcolony in the presence of flow-induced shear stress (<xref ref-type="bibr" rid="bib51">Mikaty et al., 2009</xref>). The actin cytoskeleton has also been shown to be highly reorganized underneath bacterial microcolonies, forming a structure reminiscent of a honeycomb, also called cortical plaque (<xref ref-type="bibr" rid="bib48">Merz and So, 1997</xref>; <xref ref-type="bibr" rid="bib67">Soyer et al., 2014</xref>). Although easy to use, 2D models do not recapitulate the geometry of the vascular system, the proper molecular signaling of inflammation, or the vesicular transport of proteins, all found in a 3D microenvironment (<xref ref-type="bibr" rid="bib56">Offeddu et al., 2019</xref>; <xref ref-type="bibr" rid="bib71">Wang et al., 2020</xref>). An in vitro model of meningococcal infections that recapitulates these features in a biologically relevant 3D environment is still lacking.</p><p>Producing synthetic yet functional human vasculature has been a dynamic field of research over the last decade, including establishing a 3D vascular system inside a hydrogel loaded onto a microfluidic chip. Endothelial cells are embedded into hydrogels (e.g. fibrin) to self-assemble into interconnected tubes (<xref ref-type="bibr" rid="bib34">Kim et al., 2013</xref>; <xref ref-type="bibr" rid="bib35">Ko et al., 2019</xref>; <xref ref-type="bibr" rid="bib28">Haase et al., 2020</xref>; <xref ref-type="bibr" rid="bib55">O’Connor et al., 2022</xref>). Although delivering functional vasculature, this method does not allow for control of the produced vascular geometry. Other methods consist of loading cells into pre-formed structures using molding (<xref ref-type="bibr" rid="bib27">Haase and Kamm, 2017</xref>; <xref ref-type="bibr" rid="bib13">Dessalles et al., 2021</xref>), or viscous fingering (<xref ref-type="bibr" rid="bib30">Herland et al., 2016</xref>). These approaches allow the formation of large patterns (120-150 µm) and straight structures, but vessels in tissues are tortuous, ramified, and can be as narrow as 10 µm in diameter. An alternative way for the production of synthetic vasculatures takes advantage of the photoablation technique (<xref ref-type="bibr" rid="bib64">Sarig-Nadir et al., 2009</xref>; <xref ref-type="bibr" rid="bib5">Brandenberg and Lutolf, 2016</xref>; <xref ref-type="bibr" rid="bib18">Enrico et al., 2022</xref>). This technique comes with several advantages, including compatibility with a wide range of hydrogels and maximal control over the produced geometry.</p><p>In this study, we used a homemade laser ablation setup to engineer a vascular system on-chip with tunable parameters to generate vessels of various shapes and sizes, hence reflecting the complexity of the in vivo vascular system. We were able to reproduce <italic>Neisseria meningitidis</italic> vascular colonization in vitro. Our Vessel-on-Chip model allowed simulation of the in vivo environment during the onset of meningococcal infection with higher spatiotemporal resolution using multidimensional time-lapse imaging while respecting the human specificity of the meningococcal infection. It replicates key features of the infection, including bacterial adhesion, cellular remodeling, vascular damage, and neutrophil response in infected vessels. The human skin xenograft animal model of meningococcal intravascular infection served as the gold standard to validate our Vessel-on-Chip system. This platform offers a robust bridge to animal and 2D models, providing a physiologically relevant and quantitative 3D tool for studying host-pathogen interactions in vitro.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Replicating the geometries of infected vessels using photoablation</title><p><italic>N. meningitidis</italic> infects various types of blood vessels in human cases and in the skin xenograft mouse model (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>), including arterioles, venules, and capillaries, which typically range from 10-100 µm in diameter, with an average size of 40-60 µm (<xref ref-type="bibr" rid="bib44">Manriquez et al., 2021</xref>). Furthermore, infected vessels are typically branched and exhibit diverse geometries (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Thus, to study <italic>N. meningitidis</italic> vascular colonization and subsequent vascular damage in relevant vascular geometries, we developed a Vessel-on-Chip (VoC) model using photoablation to allow for complex geometries (<xref ref-type="bibr" rid="bib5">Brandenberg and Lutolf, 2016</xref>). The chip features a central channel connected to two larger lateral channels and filled with collagen I-type gel, which acts as an extracellular matrix (<xref ref-type="bibr" rid="bib30">Herland et al., 2016</xref>). The photoablation process involves the 3D carving of the bulk collagen I matrix at the center of the microfluidic chip with a focused UV laser beam (<xref ref-type="fig" rid="fig1">Figure 1B</xref>), which was tuned to control vessel dimensions (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>). Briefly, the chosen design is digitized into a list of positions to ablate. A pulsed UV-laser beam is injected into the microscope and shaped to cover the back aperture of the objective. The laser is then focused on each position that needs ablation. After introducing endothelial cells (HUVEC) in the carved regions, they formed a vascular lumen by adhering to the substrate (<xref ref-type="fig" rid="fig1">Figure 1C</xref>) and deformed the initially squared structure, leading to a circular architecture (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>). The lateral channels remain open to ensure regular liquid flows for nutrient replenishment and the later introduction of bacteria and immune cells.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Replicating the geometries of infected in vivo vessels using photoablation.</title><p>(<bold>A</bold>) Confocal images of <italic>N. meningitidis</italic>-infected vessels in the human-skin xenograft mouse model. Scale bar: 25 µm. (<bold>B</bold>) Schematic representation of the development of the Vessel-on-Chip (VoC) device: (i) a collagen-based hydrogel is loaded in the center channel of the microfluidic device, (ii) the focused UV-laser locally carves the chosen geometry within the collagen I matrix, (iii) HUVECs are seeded and attach on the collagen-carved scaffold. (<bold>C</bold>) Schematic representation of the microfluidic device and zoom of the carved region after cell seeding (F-actin). Scale bar: 250 µm. (<bold>D</bold>) Confocal images of F-actin and the related orthogonal view of the tissue-engineering VoC. Scale bar: 50 µm. (<bold>E</bold>) Confocal images of VoC in circle-, square-, and diamond-shaped structures. Scale bar: 50 µm. (<bold>F</bold>) Photoablation process to create in vivo-like structures. Definition of the region of interest (ROI) to replicate from intravital microscopy images (left), and the obtained in vivo-like structures in the VoC (right). Scale bars: 20 µm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107813-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Development, optimization, and characterization of a tissue-engineered Vessel-on-Chip platform based on photoablation.</title><p>(<bold>A</bold>) Schematic representation of the in vivo conditions assessed in this study: human vessels imaged in the human-skin xenograft. Scale bar: 30 µm. (<bold>B</bold>) Channel height depends on UV-Laser energy for 2.4 mg/ml (FujiFilm), 4 mg/ml (Corning), and 6 mg/ml (Corning) collagen I gels. (<bold>C</bold>) Orthogonal view of a bear and endothelial-layered collagen-carved tube. Scale bar: 20 µm. (<bold>D</bold>) Collagen-carved scaffold for 2.4 mg/ml (FujiFilm), 4 mg/ml (Corning), and 6 mg/ml (Corning) collagen I gel before cell seeding. Scale bar: 50 µm. (<bold>E</bold>) Confocal image of the VoC in 2.4 mg/ml - 3.5 mg/ml - 4 mg/ml and 6 mg/ml collagen I. Fujifilm collagen I has been used to make the 2.4 mg/ml (cyan circle) and Corning collagen I has been used to make the solution from 3.5 mg/ml to 6 mg/ml (blue circle). Scale bar: 30 µm. (<bold>F</bold>) Graph representing the number of sprouts per vessel for four collagen I concentrations: 2.4 mg/ml (FujiFilm), 3.5 mg/ml, 4 mg/ml, and 6 mg/ml (Corning). Each dot represents one vessel. For each condition, the mean ±s.d. is represented (2.4 mg/ml: 5.20 ± 6.0 (n=28) — 3.5 mg/ml: 1.69 ± 3.04 (n=29) — 4 mg/ml: 0.045 ± 0.22 (n=21) — 6 mg/ml: 0.23 ± 0.43 (n=30)) (<bold>G</bold>) Visco-elasticity measurements of collagen gels with a rheometer. Each dot represents a measure of each gel. For each condition, the mean ± s.d. is represented (FujiFilm, 2.4 mg/ml: (n=3) — Corning, 2.4 mg/ml: (n=3)–3.5 mg/ml: (n=3)–4 mg/ml: (n=3)–6 mg/ml: (n=3)). The mentions (<xref ref-type="bibr" rid="bib52">Murray et al., 2022</xref>) and (<xref ref-type="bibr" rid="bib42">Mairey et al., 2006</xref>) in (<bold>D</bold>), (<bold>F</bold>), and (<bold>G</bold>) refer to the providers of the collagen I, FujiFilm and Corning, respectively.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107813-fig1-figsupp1-v1.tif"/></fig></fig-group><p>In vivo, the extracellular matrix is crucial for providing structural and organizational stability (<xref ref-type="bibr" rid="bib29">Haase et al., 2022</xref>; <xref ref-type="bibr" rid="bib11">Davis and Senger, 2005</xref>), thus warranting optimization in our VoC. Endothelial cells intensively sprouted at collagen concentrations of 2.4 mg/ml (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D, E</xref>), a phenomenon we sought to suppress to better align with the physiological conditions in vivo (<xref ref-type="bibr" rid="bib15">Dudley and Griffioen, 2023</xref>). Sprouting decreased with increasing collagen concentrations (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E, F</xref>), which correlates with the increase in gel stiffness (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1G</xref>). However, while two different collagen gels (3.5 mg/ml Corning and 2.4 mg/ml Fujifilm) exhibited a comparable elastic modulus (50 Pa), they showed different effects on the number of endothelial cell sprouts. These results suggest that, in our model, endothelial cell sprouting is determined by both the concentration and composition of collagen, which likely vary in terms of cross-linkage and pore size. Based on these findings, we used a minimum of 4 mg/ml collagen gels for the rest of our study.</p><p>The introduction of endothelial cells led to the formation of straight hollow tubes with a circular cross-section (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). The system also allowed the replication of more complex 3D structures (<xref ref-type="fig" rid="fig1">Figure 1E</xref>) and geometries of in vivo blood vessels, based on intravital imaging data. For instance, a vascular branching point, observed in a human vessel imaged in the human skin xenograft mouse model (<xref ref-type="fig" rid="fig1">Figure 1A</xref>), was accurately replicated in the VoC (<xref ref-type="fig" rid="fig1">Figure 1F</xref>). The resulting in vivo-like structure in the VoC preserved the aspect ratio of the original vascular geometry and could be further visualized at higher microscopy resolutions compared to blood vessels in animal models. In summary, the photoablation technique, when combined with optimized extracellular matrix properties, enables controlling the construction of reproducible on-chip vessels that closely mimic those targeted by the meningococci in vivo.</p></sec><sec id="s2-2"><title>The vessels in the VoC exhibit permeability levels comparable to those observed in vivo</title><p>A key feature of meningococcal infections is their association with an increase in vascular permeability (<xref ref-type="bibr" rid="bib23">Faust et al., 2000</xref>; <xref ref-type="bibr" rid="bib44">Manriquez et al., 2021</xref>). Therefore, relevant in vitro infection models should allow the observation and quantification of such a loss of vascular integrity. In this study, we assessed vascular permeability in both the VoC and in vivo blood vessels of human (skin xenograft mouse model) origin. Given that vascular integrity and permeability are dependent on intercellular junctions, we first visualized these structures in the chips. Two days post-seeding, endothelial cells formed thin and uniform junctions, as evidenced by VE-Cadherin (<xref ref-type="fig" rid="fig2">Figure 2A</xref>) and PECAM-1 (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>) stainings, confirming the cohesiveness of the engineered vessel. Additionally, we observed that endothelial cells secreted collagen IV (<xref ref-type="fig" rid="fig2">Figure 2B</xref>), a key component of the basement membrane that provides structural support to blood vessels (<xref ref-type="bibr" rid="bib37">Leclech et al., 2020</xref>). Then, to evaluate vascular integrity functionally, we performed imaging-based permeability assays using fluorescent 150 kDa dextran (<xref ref-type="fig" rid="fig2">Figure 2C</xref>), comparing fluorescence intensities inside and outside the engineered vessels within our VoC. We observed that sprouting vessels (2.4 mg/ml collagen I) exhibited high permeability, whereas those without sprouts (4 mg/ml collagen I) showed low permeability – no leakage was detected for up to 10 min, consistent with in vivo observations in the human skin xenograft (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). Altogether, these results demonstrate that our VoC forms a stable physical barrier with low permeability, closely mimicking in vivo conditions of human blood vessels in the animal model.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>The Vessel-on-Chip device provides nuclear morphologies under flow conditions and permeability levels similar to those observed in vivo.</title><p>(<bold>A</bold>) Confocal images of the VE-Cadherin staining and (<bold>B</bold>) Collagen IV in the VoC. Scale bars: 50 µm (large view) and 7 µm (zoom). (<bold>C</bold>) Representative confocal images of fluorescent 150 kDa-Dextran (FITC) in the VoC (top, scale bar: 50 µm) and in the human vessel in the mouse model (bottom, scale bar: 30 µm). Fluorescence of the outside and inside regions of the vascular lumen has been measured to determine permeability. (<bold>D</bold>) Graph representing the permeability to 150 kDa-Dextran. Each dot represents one vessel. For each condition, the mean ± s.d. is represented (VoC, 2.4 mg/ml: 65.12 ± 26.00 cm/s (n=7) – VoC, 4 mg/ml: 3.97 ± 2.49 cm/s (n=5) - Human vessel in vivo: 8.00 ± 2.52 cm/s (n=7)). (<bold>E</bold>) Representative images of nucleus alignment in the absence and presence of flow (24 hr). Scale bar: 50 µm. (<bold>F–G</bold>) Graphs of nucleus orientation (IRQ: interquartile range) and elongation. Each dot corresponds to the mean value of one vessel. For each condition, the mean ± s.d. is represented (No flow: 53.0 ± 30.2º and 1.63 ± 0.11 a.u. (n=34)–2 hr of flow: 29.9 ± 11.5º and 1.85 ± 0.25 a.u. (n=22)–24 hr of flow: 18.2 ± 7.61º and 1.98 ± 0.20 a.u. (n=25) – in vivo: 12.9 ± 4.6º and 2.01 ± 0.23 a.u. (n=9)). All statistics have been computed with Wilcoxon tests.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107813-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Endothelial cells in the Vessel-on-Chip devices respond to flow-induced shear stress.</title><p>(<bold>A</bold>) Confocal images of PECAM-1 staining of the VoC. Scale bar: 50 µm. (<bold>B</bold>) Intravital images of PIV tracking of an arteriole and a venule in the mouse model (ear skin dermis). Scale bar: 50 µm. (<bold>C</bold>) Graph representing the flow rate depending on the vessel size. The red and blue fitting curves follow the <inline-formula><alternatives><mml:math id="inf1"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>y</mml:mi><mml:mo>=</mml:mo><mml:mi>a</mml:mi><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:msup><mml:mi>x</mml:mi><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msup></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft1">\begin{document}$y = a/x^{3}$\end{document}</tex-math></alternatives></inline-formula> equation for arterioles and venules, respectively. (<bold>D</bold>) In vivo wall shear stress of blood flow in arterioles and venules in the mouse model. Each dot represents a vessel. For each condition, the mean ± s.d. is represented (Arterioles: 1.57 ± 1.05 Pa (n=31) – Venules: 0.31 ± 0.35 Pa (n=12)). (<bold>E</bold>) Schematic of VoC experiments under flow conditions, controlled with a syringe pump. (<bold>F</bold>) Representative images of nucleus alignment (top) with the corresponding segmented/color-coded image (middle) and the circular plot of orientation (bottom). Scale bar: 30 µm. (<bold>G</bold>) Graph of nucleus interquartile range (orientation) and (<bold>H</bold>) nucleus elongation according to Wall Shear Stress (WSS). (<bold>I</bold>) Vessel diameter ratio before and after cell seeding (<inline-formula><alternatives><mml:math id="inf2"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:msub><mml:mi>D</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>f</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:msub></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft2">\begin{document}$D_{after}$\end{document}</tex-math></alternatives></inline-formula>/<inline-formula><alternatives><mml:math id="inf3"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:msub><mml:mi>D</mml:mi><mml:mrow><mml:mi>b</mml:mi><mml:mi>e</mml:mi><mml:mi>f</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft3">\begin{document}$D_{before}$\end{document}</tex-math></alternatives></inline-formula>) and (<bold>J</bold>) nearest nucleus distance for no flow condition, after 2 hr and 24 hr of flow. Each dot corresponds to a vessel. For each condition, the mean ± s.d. is represented (No flow conditions: 2.02 ± 0.74 and 14.90 ± 2.40 µm (n=34)–2 hr of flow: 1.42 ± 0.31 and 15.00 ± 1.52 µm (n=22)–24 hr of flow: 1.30 ± 0.27 and 14.9 ± 1.55 µm (n=26) — Animal model: 12.30 ± 2.70 µm (n=4)). All statistics have been computed with Wilcoxon tests.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107813-fig2-figsupp1-v1.tif"/></fig></fig-group><p>Then, as flow-induced shear stress is a key factor that shapes endothelial cell physiology (<xref ref-type="bibr" rid="bib75">Zhou et al., 2023a</xref>), as well as <italic>N. meningitidis</italic> adhesion along the endothelium (<xref ref-type="bibr" rid="bib42">Mairey et al., 2006</xref>), we ensured that our model recapitulated in vivo nuclear morphologies, known as sensors of the blood flow direction (<xref ref-type="bibr" rid="bib9">Davies, 1995</xref>). By performing particle image velocimetry (PIV) experiments in anesthetized animals (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>), we measured the flow rates in blood vessels (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>) and computed the related wall shear stress (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D</xref>). Considering blood as Newtonian between 25 µm and 100 µm (<xref ref-type="bibr" rid="bib59">Pries et al., 1995</xref>), we showed a wall shear stress of 1.57 Pa (15.7 dynes/cm<sup>2</sup>) and 0.31 Pa (3.1 dynes/cm<sup>2</sup>) in arterioles and venules, respectively – consistent with previous studies (<xref ref-type="bibr" rid="bib9">Davies, 1995</xref>; <xref ref-type="bibr" rid="bib57">Osinnski et al., 1995</xref>; <xref ref-type="bibr" rid="bib58">Peng et al., 2019</xref>). Under venule-like flow conditions controlled by a syringe pump (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1E</xref>), the nucleus of endothelial cells aligned along the flow direction (<xref ref-type="fig" rid="fig2">Figure 2E</xref>) and reached both elongation and orientation of in vivo features after 24 hr of flow exposure (<xref ref-type="fig" rid="fig2">Figure 2F, G</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1F</xref>). Of note, nucleus orientation and elongation reached a constant value at 24 hr (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1G, H</xref>), suggesting a homogeneous behavior regardless of wall shear stress for long-term flow exposure. Also, vessel diameter decreased when endothelial cells were subjected to flow, while cell density remained constant across all conditions (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1I, J</xref>). Altogether, these results show that our VoC model correctly responds to flow-induced shear stress and recapitulates the physiological features of the animal model in terms of vascular nucleus morphology and permeability levels.</p></sec><sec id="s2-3"><title>Adhesion of <italic>N. meningitidis</italic> on chip depends on type-4 pili, while geometry-induced shear stress variations have little impact</title><p>The developed in vitro vessels allowed us to study meningococcal infection in a controlled 3D environment. Bacteria were introduced into the microfluidic device and circulated through the lumen (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Consistent with observations in infected patients and in the human skin xenograft mouse model (<xref ref-type="bibr" rid="bib47">Melican et al., 2013</xref>), meningococci were found to attach to the vascular wall within the infected VoC (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). <italic>N. meningitidis</italic> covered the three-dimensional areas of the endothelium and adhesion occurred both in straight and in vivo-like structures (<xref ref-type="fig" rid="fig3">Figure 3B</xref>), forming 3D microcolonies of varying sizes, ranging from a few to tens of microns, as observed in the original geometry in vivo. Overall, the infected Vessel-on-Chip model replicates meningococcal vascular colonization in a 3D context and enables high-resolution fluorescence microscopy for detailed monitoring of the infection process in vitro.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title><italic>Neisseria meningitidis</italic> adhesion to the Vessel-on-Chip device.</title><p>(<bold>A</bold>) Schematic of the infected Vessel-on-Chip device. (<bold>B</bold>) Confocal images of infected vessels in the VoC system 3 hr post-infection, in each condition. Top-left: z-projection of the infected VoC; top-right: slice of the middle of the infected VoC; bottom-left: 3D reconstruction of the infected VoC; and bottom-right: z-projection of the infected in vivo-like VoC. Scale bar: 20 µm. (<bold>C</bold>) Bright-field and fluorescence confocal images of the VoC 3 hr post-infection with WT (top) and <italic>pilD</italic> (bottom) <italic>Nm</italic> strains. Scale bar: 25 µm. (<bold>D</bold>) Graph representing the number of aggregates 3 hr post-infection, with wild-type (WT) and <italic>pilD Nm</italic> strains. 17 µm<sup>2</sup> represents the median over the entire population of aggregate sizes. Each dot corresponds to a vessel. For each condition, the mean ± s.d. is represented (WT: 47.5 ± 30.4 (n=2) – <italic>pilD</italic>: 2.0 ±2.0 (n=3)). (<bold>E</bold>) Brightfield (left) and fluorescence (center) images of the infected vessels of different designs (circle, diamond, in vivo-like) and related simulation of shear stress. Scale bar: 50 µm. (<bold>F</bold>) Normalized histograms of the total number of pixels (blue dots and curve) and bacteria pixels (orange dots and curve) depending on the shear stress values for each vessel design (from top to bottom, circle, diamond, in vivo-like). Solid curves represent the mean ± sd (n=3 experiments). Spearman correlation gives the correlation between the mean curves.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107813-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title><italic>Neisseria meningitidis</italic> uses T4P to adhere on the Vessel-on-Chip and its adhesion does not depend on the difference of shear stress.</title><p>(<bold>A–B</bold>) Graphs representing the numbers and the sizes of microcolonies within the VoC infected with wild-type (WT) or <italic>pilD Nm</italic> strains. For each condition, the mean ± s.d. is represented (WT: 189.0 ± 72.1 (n=2 vessels) and 16.60 ± 3.39 µm<sup>2</sup> (n=378 microcolonies) – <italic>pilD</italic>: 14.3 ± 12.1 (n=3 vessels) and 9.03 ± 4.47 µm<sup>2</sup> (n=43 microcolonies)). (<bold>C</bold>) Analysis pipeline of the correlation between bacterial location and shear stress in Vessel-on-Chip.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107813-fig3-figsupp1-v1.tif"/></fig></fig-group><p>We confirmed the role of type IV pili-mediated adhesion in the VoC model by comparing a wild-type strain (WT) with the type IV pili-deficient <italic>pilD</italic> mutant strain. After 3 hr of infection under flow, we observed that infection of the VoC with the <italic>pilD</italic> mutant strain only contained rare <italic>N. meningitidis</italic> aggregates (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). In contrast, infection with the WT strain resulted in the formation of numerous and large microcolonies on the vascular walls of the VoC (<xref ref-type="fig" rid="fig3">Figure 3D</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A and B</xref>).</p><p>We next investigated whether vascular geometry and associated shear stress variations affect <italic>N. meningitidis</italic> adhesion, i.e., whether <italic>Neisseria meningitidis</italic> exhibits preferential sites of infection across vascular geometries. We hypothesized that, if bacteria preferentially adhered to specific regions, the local shear stress at these sites would differ from the overall distribution. To this end, we infected vessel-on-chip models of increasing geometrical complexity, circle, diamond, and in vivo-like branched structures, generating distinct wall shear stress profiles (<xref ref-type="fig" rid="fig3">Figure 3E</xref>), from 0.025 to 0.1 Pa (<xref ref-type="fig" rid="fig3">Figure 3F</xref>). Thanks to a segmentation routine coupled with Comsol simulations (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>), we compared the shear stress at bacterial adhesion sites in the VoC (orange dots and curve) with the shear stress along the entire vascular edges (blue dots and curve) (<xref ref-type="fig" rid="fig3">Figure 3F</xref>). The distribution of adherent bacteria as a function of shear stress level (orange curve) closely mirrored the shear stress distribution available in the device (blue curve), indicating no preferential adhesion sites across shear stress gradients. This was confirmed by Spearman correlation analysis, which showed strong correlations between the two mean curves (0.58 &lt; S. corr. &lt; 0.83) (<xref ref-type="fig" rid="fig3">Figure 3F</xref>). These findings suggest that within this flow range, adhesion is not impacted by geometry-induced shear stress variations, consistent with in vivo observations and previous studies (<xref ref-type="bibr" rid="bib42">Mairey et al., 2006</xref>).</p></sec><sec id="s2-4"><title>Progression of <italic>N. meningitidis</italic> colonization in the Vessel-on-Chip is similar to in vivo observations</title><p>In both the VoC and animal model, we observed the fusion of bacterial aggregates (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>), highlighting the dynamical properties of bacterial expansion (<xref ref-type="bibr" rid="bib4">Bonazzi et al., 2018</xref>; <xref ref-type="bibr" rid="bib62">Rossy et al., 2023</xref>). We then challenged the impact of flows in bacterial growth and morphology. Microcolony expansion was thus assessed under flow (0.5 µl/min which corresponds to ∼ 0.1 Pa) by monitoring the increase of surface area covered by adherent bacteria over 3 hr of infection, as in vivo experiments (<xref ref-type="fig" rid="fig4">Figure 4A</xref> and <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>). Individual microcolonies (shaded curves, <xref ref-type="fig" rid="fig4">Figure 4A</xref>) exhibited a mean linear growth trend (solid curve) in both the VoC model and the mouse model. We normalized the quantification of the colony doubling time according to the first time point where a single bacterium is attached to the vessel wall. We observed that the time required for microcolony expansion in both VoC (with and without flow) and human skin-grafted mice is similar (approximately 20 min, <xref ref-type="fig" rid="fig4">Figure 4B</xref>), and is lower than in agar-pad cultures (30-40 min <xref ref-type="bibr" rid="bib20">Ershov et al., 2022</xref>). This trend likely reflects a combination of bacterial proliferation, fusion, and subsequent adhesion of circulating bacteria, as previously proposed (<xref ref-type="bibr" rid="bib22">Eugène et al., 2002</xref>). We then observed that, under flow conditions, bacterial microcolonies were submitted to a morphological change within the VoC (<xref ref-type="fig" rid="fig4">Figure 4C and D</xref>). Microcolonies elongated and aligned along the vessel length, corresponding to the direction of flow. Unlike under static conditions, both elongation and orientation properties of bacterial microcolonies in the presence of flow were similar to those found in viv<italic>o</italic>, demonstrating the importance of the flow to recapitulate the proper infection conditions in the VoC. Altogether, these findings demonstrate that our model effectively replicates the key aspects of <italic>N. meningitidis</italic> colonization, including bacterial dynamics, morphology, and functional behavior, closely mirroring the infection process observed in vivo.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Flow impacts colony morphology but not growth in both Vessel-on-Chip and animal models, and <italic>N. meningitidis</italic> infection increases permeability in Vessel-on-Chip.</title><p>(<bold>A</bold>) Normalized surface area of microcolonies over time, in the VoC under flow conditions (left, n=20) and in human vessels of the xenografted mouse model (right, n=33). Solid thin curves, solid thick curves, and dashed thick curves represent individual colony growth, mean, and linear fit (y=ax + 1), respectively. (<bold>B</bold>) Colony doubling time extracted from the curves (<inline-formula><alternatives><mml:math id="inf4"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft4">\begin{document}$t_{d}$\end{document}</tex-math></alternatives></inline-formula> = 1/a). Each dot corresponds to a bacterial microcolony. For each condition, the mean ± s.d. is represented (VoC, Flow<sup>–</sup>: 16.7 ± 18.5 min (n=21) — VoC, Flow<sup>+</sup> : 26.2 ± 40.4 min (n=20) — in vivo: 15.2 ± 18.8 min (n=33)). (<bold>C</bold>) Confocal images of wild-type (WT) <italic>Nm</italic> microcolonies formed on the vascular wall 3 hr post-infection, in the absence and presence of flow (VoC), and in the animal model. Scale bar: 10 µm. Circular plots representing the distribution of microcolony orientation. (<bold>D</bold>) Graph representing the elongation of microcolonies 3 hr post-infection in each condition. Each dot corresponds to a microcolony. For each condition, the mean ± s.d. is represented (VoC, Flow<sup>–</sup> : 1.75 ± 0.77 (n=128) — VoC, Flow<sup>+</sup> : 2.11 ± 1.02 (n=125) — in vivo: 2.07 ± 0.971 (n=61)). (<bold>E</bold>) Brightfield and fluorescence confocal images of permeability assay (Dextran) in infected (top) and histamine-treated (bottom) Vessel-on-Chips. Scale bar: 25 µm. (<bold>F</bold>) Relative permeability values of VoC and in vivo vessels treated with histamine and infected with <italic>Nm</italic>. Each dot represents a vessel. For each condition, the mean ± s.d. is represented (mouse vessel, Control: 1 ± 0.62 (n=5), Histamine: 3.79 ± 2.25 (n=5) — VoC, Control: 1 ± 0.63 (n=5), Histamine: 5.11 ± 3.92 (n=7), <italic>Nm</italic>: 11.3 ± 5.48 (n=7)). All statistics have been computed with Wilcoxon tests.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107813-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title><italic>N</italic>. <italic>meningitidis</italic> colonies grow and reorganize in vitro under flow conditions, and in vivo permeability is not affected by <italic>N. meningitidis</italic> at early stages of infection.</title><p>(<bold>A</bold>) Time-lapse images of bacterial growth in a Vessel-on-Chip (VoC) and an infected human vessel in the skin-xenografted mouse model. Scale bar: 30 µm. (<bold>B</bold>) Zoom on a bacterial fusion event in a VoC (top) and in a human skin-grafted mouse model (bottom). Scale bar: 10 µm. (<bold>C</bold>) Permeability of infected human vessels in the human skin-xenografted mouse model (green), normalized with the permeability of non-infected vessels (gray). For each condition, the mean ± s.d. is represented 70 kDa - Control: 1 ± 0.542 (n=11 vessels, N=3 mice), <italic>Nm</italic>: 1.34 ± 0.603 (n=11 vessels, N=3 mice) — 150 kDa - Control: 1 ± 0.314 (n=7 vessels, N=3 mice), <italic>Nm</italic>: 0.989 ± 0.280 (n=5 vessels, N=3 mice). Statistics have been done with Wilcoxon tests.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107813-fig4-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-5"><title><italic>N. meningitidis</italic> vascular colonization increases vessel permeability within the Vessel-on-Chip</title><p>Vascular permeability was shown to increase at the late stages of meningococcal infections (24 hr post-infection), as evidenced in the human skin xenograft mouse model by the accumulation of intravenously injected Evans blue in the surrounding tissues (<xref ref-type="bibr" rid="bib44">Manriquez et al., 2021</xref>). We, therefore, used a direct permeability assay using a 150 kDa FITC Dextran in both the VoC and the mouse model (<xref ref-type="fig" rid="fig4">Figure 4E and F</xref>) to determine the permeability at the early stage of inflammation and infected vessels. Histamine was used as a positive control (<xref ref-type="bibr" rid="bib16">Egawa et al., 2013</xref>), showing a similar response under inflammatory conditions in both the in vivo and VoC models (<xref ref-type="fig" rid="fig4">Figure 4E and F</xref>). After 3 hr post-infection, vascular permeability importantly increased in the infected VoC, consistent with findings from previous 2D in vitro studies (<xref ref-type="bibr" rid="bib36">Kobsar et al., 2011</xref>; <xref ref-type="bibr" rid="bib17">Endres et al., 2022</xref>; <xref ref-type="bibr" rid="bib65">Schubert-Unkmeir et al., 2010</xref>; <xref ref-type="bibr" rid="bib77">Ziveri et al., 2024</xref>). In contrast, only a subtle increase in vascular permeability was observed in infected human vessels in the skin xenograft mouse model (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>), most likely reflecting the presence of additional cell types surrounding the vessel wall in vivo, which enhance barrier integrity at early stages of infection (<xref ref-type="bibr" rid="bib17">Endres et al., 2022</xref>). In addition, at later stages of infections, vascular integrity might also be affected by intravascular coagulation induced by meningococci (<xref ref-type="bibr" rid="bib7">Corre et al., 2022</xref>). Overall, our results show that, despite moderate differences between the VoC and the animal model in the kinetics of endothelial integrity loss, the VoC offers a suitable model to study the direct consequences, including the increase in vessel permeability, of the host-pathogen interaction between <italic>N. meningitidis</italic> and endothelial cells upon vascular colonization with a high spatiotemporal resolution.</p></sec><sec id="s2-6"><title>Flow-induced aligned actin stress fibers are reorganized beneath bacterial microcolonies</title><p><italic>N. meningitidis</italic> bacterial microcolonies have been shown to reorganize both the plasma membrane and the actin cytoskeleton upon adhesion at the surface of endothelial cells in 2D models (<xref ref-type="bibr" rid="bib6">Charles-Orszag et al., 2018</xref>; <xref ref-type="bibr" rid="bib67">Soyer et al., 2014</xref>; <xref ref-type="bibr" rid="bib49">Merz et al., 1999</xref>). However, in vivo, such events are challenging to observe.</p><p>Also, endothelial cells experience flow-induced mechanical stresses in vivo, which is known to influence the state of the actin cytoskeleton (<xref ref-type="bibr" rid="bib43">Malek and Izumo, 1996</xref>; <xref ref-type="bibr" rid="bib10">Davies, 2009</xref>). The impact of such actin cytoskeleton rearrangements, potentially impacting bacteria-induced responses, has never been explored. This requires a high-resolution imaging of infection within a perfused 3D environment, which is provided by our system. Thus, within the micro-physiological environment of the Vessel-on-Chip model, we investigated whether similar actin reorganization in endothelial cells occurs upon infection by <italic>N. meningitidis</italic>. We first confirmed that, in the absence of flow, actin stress fibers exhibit random orientations (<xref ref-type="fig" rid="fig5">Figure 5A and B</xref>). In contrast, when endothelial cells in the VoC were submitted to flow for 2 hr, actin stress fibers became highly organized and aligned with the flow direction (<xref ref-type="fig" rid="fig5">Figure 5A and B</xref>). Notably, this rapid adaptation was quantitatively confirmed by the significant reduction in the interquartile range (IQR) of fiber orientation when increasing shear stress levels, regardless of the duration (2 hr or 24 hr) of flow exposure (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Flow-induced aligned actin stress fibers are reorganized below bacterial microcolonies.</title><p>(<bold>A</bold>) Confocal images of the F-actin network in the Vessel-on-Chip (VoC) in the absence and presence of flow (2 hr and 24 hr) (top). Scale bar: 30 µm. Corresponding segmented images. The color code shows the alignment of the actin fibers with the direction of the flow (red to blue) (middle). Circular plots of the orientation distribution of actin fibers (bottom). (<bold>B</bold>) Interquartile range of F-actin fiber orientation. Each dot represents the mean of F-actin fiber orientation per vessel. For each condition, the mean ± s.d. is represented (No Flow: 68.8<sup>º</sup> ± 31.0<sup>º</sup> (n=29) — 2 hr of flow: 33.1<sup>º</sup> ± 14.3<sup>º</sup> (n=25) — 24 hr of flow: 35.5<sup>º</sup> ± 13.5<sup>º</sup> (n=19)). (<bold>C</bold>) Confocal images of honeycomb-shaped cortical plaque formed by <italic>Nm</italic> microcolonies in the absence (top) and presence of flow (bottom) in the VoC. Scale bar: 10 µm. (<bold>D</bold>) 3D rendering of a vessel infected with <italic>Nm</italic> 3 hr post-infection under flow conditions. Scale bar: 15 µm (main) and 10 µm (zoom). (<bold>E</bold>) Percentages of colonies forming a cortical plaque in the 3D VoC (n=5 vessels) and 2D regions of the chips (n=4 lateral channels). (<bold>F</bold>) F-actin fluorescence intensity under each microcolony and on non-infected regions of the same area. Each dot represents a region of a microcolony. For each condition, the mean ± s.d. is represented (Not infected regions: 0.99 ± 0.33 a.u. (n=74) — Infection, without cortical plaque: 1.30 ± 0.57 a.u. (n=36) — Infection, with cortical plaque: 2.15 ± 0.54 a.u. (n=28)). (<bold>G</bold>) Coherency of F-actin fibers on non-infected regions and infection sites. Each dot represents a colony. For each condition, the mean ± s.d. is represented (Not infected regions: 0.40 ± 0.17 a.u. (n=74) — Infection, without cortical plaque: 0.28 ± 0.15 a.u. (n=36) — Infection, with cortical plaque: 0.18 ± 0.09 a.u. (n=28)). All statistics have been computed with Wilcoxon tests.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107813-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Flow-induced aligned actin stress fibers are reorganized below <italic>N. </italic><italic>meningitidis</italic> microcolonies.</title><p>(<bold>A</bold>) Interquartile range of actin fibers according to the flow-induced wall shear stress. (<bold>B</bold>) Confocal images of F-actin cortical plaque at the infection sites in the 2D regions of the chips (n=5 chips, n=3 experiments). Scale bar = 40 µm. (<bold>C</bold>) Graph representing the correlation between F-actin mean fluorescence intensity and actin fiber coherency.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107813-fig5-figsupp1-v1.tif"/></fig></fig-group><p>Despite the flow-mediated alignment of the actin fibers, bacterial microcolonies adhering at the surface of endothelial cells in the VoC were able to induce the formation of the honeycomb-shaped actin structures underneath bacterial aggregates, similar to observations made in infection in the absence of flow (<xref ref-type="fig" rid="fig5">Figure 5C and D</xref>). This specific bacteria-induced reorganization of the actin cytoskeleton, which occurs under flow conditions, mirrors the flow-driven elongated shape of the bacterial microcolonies. After 3 hr of infection, 65% of the microcolonies had formed the actin cortical plaque below bacterial aggregates, while 35% did not show any visible structure (<xref ref-type="fig" rid="fig5">Figure 5E</xref>), which is close to the 2D experiments (<xref ref-type="fig" rid="fig5">Figure 5E</xref> and <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B</xref>). The fluorescence intensity of F-actin beneath the microcolonies was twice as high compared to non-infected areas (<xref ref-type="fig" rid="fig5">Figure 5F</xref>), reaching levels previously observed in 2D models (<xref ref-type="bibr" rid="bib67">Soyer et al., 2014</xref>). The highly organized actin fibers in the VoC were drastically reorganized by the presence of the bacterial microcolonies, as evidenced by the reduction in actin fiber coherency (fiber symmetry) upon infection (<xref ref-type="fig" rid="fig5">Figure 5G</xref>). Noticeably, F-actin fluorescence intensity was correlated with actin fiber reorganization (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>). Collectively, these results demonstrate that <italic>N. meningitidis</italic> reorganizes the endothelial cell actin cytoskeleton in the VoC under flow conditions, despite the presence of a pre-existing highly organized and aligned F-actin network. This is of particular importance when considering the infection process in vivo – during which endothelial cells are submitted to flow-induced wall shear stress – leads to actin fiber alignment and high symmetry before bacterial adhesion.</p></sec><sec id="s2-7"><title>Neutrophils respond to <italic>N. meningitidis</italic> infection in a similar manner to that observed in the animal model</title><p>The presence of an inflammatory infiltrate, predominantly composed of neutrophils, in the vicinity of infected vessels is another cardinal feature of meningococcal infection (<xref ref-type="bibr" rid="bib66">Sotto et al., 1976</xref>). Previous in vivo studies have demonstrated that <italic>N. meningitidis</italic> infection leads to the recruitment of neutrophils along infected venules, a process driven by the bacteria-mediated upregulation of E-selectin expression at the surface of infected endothelial cells (<xref ref-type="bibr" rid="bib44">Manriquez et al., 2021</xref>). To assess whether this aspect of the infection can be recapitulated within the VoC upon meningococcal infection, we examined E-selectin expression in response to inflammatory stimuli and infection. Endothelial cells did not express E-selectin in the absence of infection (<xref ref-type="fig" rid="fig6">Figure 6A</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A and B</xref>), clearly demonstrating that the experimental setup successfully maintained appropriate basal conditions all along vessel formation. In contrast, both TNFα stimulation and <italic>N. meningitidis</italic> infection led to a statistically significant increase in E-selectin expression all over the vessel (<xref ref-type="fig" rid="fig6">Figure 6A</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A and B</xref>). This is due to both the increase in the number of E-selectin<sup>+</sup>-activated cells (<xref ref-type="fig" rid="fig6">Figure 6B</xref>) and the massive upregulation of E-selectin expression of these activated cells (<xref ref-type="fig" rid="fig6">Figure 6C</xref>) at the single-cell level. Interestingly, infection with the non-piliated <italic>pilD</italic> mutant strain induced E-selectin expression to a much lesser extent when compared to the wild-type strain, highlighting the role of bacterial pilus-mediated adhesion (<xref ref-type="fig" rid="fig6">Figure 6A</xref> and <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1C</xref>). The expression of E-selectin on <italic>N. meningitidis</italic>-infected endothelium was more spatially heterogeneous than on the TNFα-inflamed one, although there no direct spatial connection with bacterial adhesion (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A and B</xref>), suggesting a spatial cell-to-cell heterogeneity in endothelial cell response upon infection, which correlates with in vivo observations (<xref ref-type="bibr" rid="bib44">Manriquez et al., 2021</xref>).</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>The infection model recapitulates the human neutrophil response to <italic>N.</italic> <italic>meningitidis</italic> infection.</title><p>(<bold>A</bold>) Confocal images of E-selectin staining in the Vessel-on-Chip (VoC) for four conditions: without infection nor treatment, after 4 hr of either TNFα treatment or infection with wild-type (WT) or <italic>pilD Nm</italic> strains. Scale bar: 50 µm. (<bold>B–C</bold>) Graphs representing the percentage of E-selectin-positive cells and the mean intensity of CD62 in positive cells. For each condition, the mean ± s.d. is represented (Control: 0.32 ± 0.67%–(n=10 vessels), 11.4 ± 1.17 (n=2 cells) — TNFα: 72.0 ± 15.0%–(n=9 vessels), 245 ± 100 (n=244 cells) — WT: 33.1 ± 8.12%–(n=8 vessels), 223 ± 118 (n=126 cells) — <italic>pilD</italic>: 14.9 ± 8.1%–(n=10 vessels), 144 ± 58.4 (n=44 cells)). (<bold>D</bold>) Schematic representation of the setup. Purified neutrophils were introduced in the microfluidic chip under flow conditions (0.7–1 µl/min). (<bold>E</bold>) Bright-field and fluorescence images of neutrophils adhering on a non-treated (control), TNFα-treated, or <italic>Nm</italic>-infected VoC. Scale bar: 25 µm. (<bold>F</bold>) Graph representing the number of neutrophils adhering to the endothelium for each condition. Each dot represents a vessel. For each condition, the mean ± s.d. is represented (Control: 0.59 ± 1.32 µm<sup>-2</sup> (n=5) — TNFα: 33.0 ± 36.1 µm<sup>-2</sup> (n=8) — <italic>N. meningitidis</italic>: 21.5 ± 28.4 µm<sup>-2</sup> (n=6)). (<bold>G</bold>) Representative images of bacteria phagocytosis by neutrophils in infected VoC (left) and in infected human vessels in the grafted mouse model (right). Scale bar: 25 µm. All statistics have been computed with Wilcoxon tests.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107813-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>The infected Vessel-on-Chip model recapitulates the human neutrophil response to <italic>N.</italic> <italic>meningitidis</italic> infection.</title><p>(<bold>A–C</bold>) Brightfield and fluorescence confocal images of a VoC before (-) and after (+) 4 hr of TNFα treatment, or infection of wild-type (WT) or <italic>pilD Nm</italic> strains (top). Graph of the E-selectin mean fluorescence intensity quantification for each condition (bottom). Each dot represents a vessel. For each condition, the mean ± s.d. is represented (TNFα - Before treatment: 1.85 ± 3.85–4 hr post treatment: 224.0 ± 93.7 (n=17) — WT - Before infection: 1.42 ± 1.02–4 hr p.i.: 105.0 ± 54.4 (n=17) — <italic>pilD</italic> - Before infection: 1.42 ± 1.02–4 h p.i.: 105.0 ± 54.4 (n=9)) Statistics have been computed with t-tests. (<bold>D</bold>) Time-lapse of the adhesion cascade of human neutrophils on the human endothelium (VoC). (<bold>E</bold>) Time-lapse of the adhesion cascade of mouse neutrophils on the mouse endothelium (mouse ear skin).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107813-fig6-figsupp1-v1.tif"/></fig></fig-group><p>We next assessed the local recruitment of neutrophils to the infected on-chip model. To this end, human neutrophils were purified from the blood of healthy donors and perfused under flow conditions in the microfluidic chip (<xref ref-type="fig" rid="fig6">Figure 6D</xref>). <xref ref-type="fig" rid="fig6">Figure 6E and F</xref> show the increase in the numbers of neutrophils attaching to the VoC wall upon inflammatory stimulation, whether with TNFα or <italic>N. meningitidis</italic>-induced intravascular colonization, compared to control conditions, consistent with in vivo recruitment of neutrophils to infected vessels (<xref ref-type="bibr" rid="bib47">Melican et al., 2013</xref>). We also observed phagocytosis of bacteria by human neutrophils (<xref ref-type="fig" rid="fig6">Figure 6G</xref>), which is comparable to that observed in the humanized mouse model (<xref ref-type="bibr" rid="bib44">Manriquez et al., 2021</xref>). In addition, we could observe the typical cascade of human neutrophil adhesion events, including rolling, arrest, and crawling on the endothelial surface (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1D and E</xref>), as previously described (<xref ref-type="bibr" rid="bib39">Ley et al., 2007</xref>). Altogether, these results demonstrate that we have successfully recapitulated the full spectrum of human immune-endothelial cell interactions, from the adhesion cascade to neutrophil recruitment and phagocytosis at infection sites, demonstrating that our VoC is suitable for studying the immune response during <italic>N. meningitidis</italic> infection. Furthermore, in contrast to the humanized mouse model, which is limited by the interactions of murine immune cells with human-infected endothelial cells, our Vessel-on-Chip model has the potential to capture the human neutrophil response during vascular infections in a species-matched microenvironment.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In this work, we have developed an in vitro 3D human Vessel-on-Chip microfluidic-based platform that accurately mimics the vascular environment encountered by <italic>N. meningitidis</italic> during intravascular colonization. We not only characterized our model from the microfabrication to the cellular response under infection conditions, but we also demonstrated that our VoC strongly replicates key aspects of the in vivo human skin xenograft mouse model, the gold standard for studying meningococcal disease under physiological conditions. The <italic>N. meningitidis</italic>-infected VoC offers several distinct advantages described below, bridging the current gap between 2D in vitro and animal models for studying vascular infections.</p><p>The first advantage of our model is its ability to replicate complex in vivo-like vessel geometries. Although photoablation is often considered practically slow (<xref ref-type="bibr" rid="bib55">O’Connor et al., 2022</xref>), our optimized process enables fast replication of complex geometries, thus facilitating the preparation of tens of devices in an hour. The speed capabilities drastically improve with the pulsing repetition rate. Given that our laser source emits pulses at 10 kHz, as compared to other photoablation lasers with repetitions around 100 Hz, our solution could potentially gain a factor of 100 in ablation speed. Also, we precisely controlled the size and shape of the UV-carved hydrogel scaffolds, enabling the replication of tissue-engineered VoC structures derived from intravital images, including straight, branched, and tortuous configurations. Vascular geometries, known to disturb streamlines and wall shear stress (<xref ref-type="bibr" rid="bib10">Davies, 2009</xref>), have been implicated in the initial formation of atherosclerosis (<xref ref-type="bibr" rid="bib76">Zhou et al., 2023b</xref>) and may also contribute to bacterial colonization in regions of low velocity (<xref ref-type="bibr" rid="bib75">Zhou et al., 2023a</xref>). Our tunable system thus represents a unique tool to further explore how vascular geometries and shear stress impact vascular colonization in different conditions.</p><p>A second significant advantage of our VoC is the replication of endothelial tissue in an in vivo-like physiological state. This includes vessels of low permeability, with well-defined intercellular junctions, and able to dynamically maintain their integrity. Perfusing the microfluidic chips enables a flow-mediated wall shear stress, leading to the reorientation of actin fibers and the elongation of nuclei, similar to what we observed in the in vivo conditions. These findings demonstrate that our system successfully replicates the in vivo conditions of endothelial cells, emphasizing the physiological relevance of our approach and creating a realistic in vitro microenvironment to study <italic>N. meningitidis</italic> vascular infection.</p><p>In the Vessel-on-Chip, the colonization of <italic>N. meningitidis</italic> increases vessel permeability, also aligning with expectations from previous in vitro studies (<xref ref-type="bibr" rid="bib36">Kobsar et al., 2011</xref>; <xref ref-type="bibr" rid="bib17">Endres et al., 2022</xref>; <xref ref-type="bibr" rid="bib65">Schubert-Unkmeir et al., 2010</xref>). In vivo, such an increase in permeability is only subtly visible after a few hours of infection but typically manifests at later stages (around 24 hr post-infection <xref ref-type="bibr" rid="bib44">Manriquez et al., 2021</xref>). This difference is most likely associated with the presence of other cell types (e.g<italic>.</italic> fibroblasts, pericytes, perivascular macrophages) in the in vivo tissues and the onset of intravascular coagulation (<xref ref-type="bibr" rid="bib7">Corre et al., 2022</xref>; <xref ref-type="bibr" rid="bib54">Obino and Duménil, 2019</xref>). Coagulation has recently been successfully recapitulated in 3D vascular models under healthy conditions (<xref ref-type="bibr" rid="bib50">Middelkamp et al., 2023</xref>), suggesting that our system could also be used to study the later stages of infection and the associated coagulation process.</p><p>Likewise, while perivascular cells and fibroblasts have been extensively studied in in vitro models (<xref ref-type="bibr" rid="bib56">Offeddu et al., 2019</xref>; <xref ref-type="bibr" rid="bib41">Long et al., 2025</xref>), their influence on <italic>N. meningitidis</italic>/host interactions have not been explored, and our setup would permit these types of studies. Recent studies show that substrate stiffness, through tissue remodeling, can affect bacterial adhesion (<xref ref-type="bibr" rid="bib24">Feng et al., 2023</xref>) and uptake (<xref ref-type="bibr" rid="bib40">Liu et al., 2021</xref>). We hypothesize that fibroblasts, by remodeling the ECM (<xref ref-type="bibr" rid="bib74">Zhao et al., 2024</xref>), and perivascular cells, by enhancing mechanical stability and secreting the basement membrane (<xref ref-type="bibr" rid="bib25">Franca et al., 2025</xref>), can alter vascular tissue and thus locally influence <italic>N. meningitidis</italic>-endothelium interactions, which can have larger consequences during vascular infection. Pericytes and endothelial cells can be co-seeded in the chips, as they have been shown to self-organize and spatially segregate within hours after seeding (<xref ref-type="bibr" rid="bib41">Long et al., 2025</xref>). Fibroblasts, by contrast, must be embedded in the collagen before polymerization. Optimization is required to preserve chip integrity since fibroblasts generate contractile forces while migrating through the gel (<xref ref-type="bibr" rid="bib38">Lee et al., 2017</xref>). Incorporating perivascular cells alongside other microvascular cell types within the physiological microenvironment of our model to dissect their roles in host–pathogen interactions will be of interest in the context of future studies.</p><p>The infected Vessel-on-Chip model also replicates the dynamics, morphology, and dependency of T4P for efficient intravascular colonization. <italic>N. meningitidis</italic> introduced in the VoC readily adheres along the endothelium and forms three-dimensional microcolonies that increase in size at a rate comparable to in vivo conditions. The microcolony shift in morphology we observed between no-flow and flow conditions is likely a consequence of the influence of shear stress on these viscoelastic structures (<xref ref-type="bibr" rid="bib4">Bonazzi et al., 2018</xref>; <xref ref-type="bibr" rid="bib72">Welker et al., 2018</xref>; <xref ref-type="bibr" rid="bib8">Craig et al., 2019</xref>). While geometry-induced shear stress gradients did not strongly impact <italic>N. meningitidis</italic> adhesion, flow could have significant implications for the dynamics of vascular colonization by spreading adherent meningococcal microcolonies along the endothelium. Following their initial T4P-mediated adhesion at the surface of endothelial cells, meningococci subsequently reorganize the actin cytoskeleton within the on-chip model, leading to the formation of the typical honeycomb-shaped cortical plaque (<xref ref-type="bibr" rid="bib48">Merz and So, 1997</xref>; <xref ref-type="bibr" rid="bib67">Soyer et al., 2014</xref>). This sheds light on the capacity of <italic>N. meningitidis</italic> to reorient the initially organized, parallel actin network in the 3D microenvironment and underscore its importance for colony stabilization, as observed in 2D and in vivo (<xref ref-type="bibr" rid="bib51">Mikaty et al., 2009</xref>; <xref ref-type="bibr" rid="bib62">Rossy et al., 2023</xref>).</p><p>While this study focused on Type IV pili (T4P)-mediated adhesion, additional type IV pili-mediated functionalities, such as twitching motility can be explored using our VoC model. Twitching motility, driven by T4P retraction via the PilT ATPase, is crucial for bacterial colonization and microcolony formation on host surfaces (<xref ref-type="bibr" rid="bib4">Bonazzi et al., 2018</xref>; <xref ref-type="bibr" rid="bib19">Eriksson et al., 2015</xref>). The PilT mutant, which retains adhesion capabilities but lacks pilus retraction, serves as an ideal model to dissect the role of twitching motility in vitro. By comparing wild-type and PilT-deficient strains within the VoC, future studies could assess differences in bacterial movement, microcolony dynamics, and interactions with endothelial cells under shear stress conditions.</p><p>Finally, our model recapitulates the microenvironment required to study the human neutrophil response in contact with infected human endothelial cells. Unlike the humanized skin xenograft mouse model that involves heterotypic interactions between murine neutrophils and human endothelium (<xref ref-type="bibr" rid="bib44">Manriquez et al., 2021</xref>), the VoC model allows for species-matched interactions between purified human neutrophils and human endothelial cells. While in basal conditions, no sign of inflammation was detected, <italic>N. meningitidis</italic> infection led to the upregulation of E-selectin on the endothelial surface and the increase of neutrophil adhesion on the vascular wall, leading to bacterial phagocytosis. These behaviors, including rolling, crawling, and active phagocytosis of adherent <italic>N. meningitidis</italic>, closely mirror immune responses observed in vivo (<xref ref-type="bibr" rid="bib44">Manriquez et al., 2021</xref>). In addition, we observed that the <italic>pilD</italic> mutant strain, which lacks T4P, triggers a milder E-selectin upregulation, indicating that T4P-mediated adhesion plays a significant role in endothelial cell activation, thereby enhancing the subsequent neutrophil adhesion. The VoC model also facilitates quantitative measurements of key parameters, as illustrated by our ability to finely assess vessel permeability or detect E-selectin upregulation at the single-cell level, capturing both the number and intensity of individual activated cells. Reaching such a level of detail is often challenging in animal models due to geometric and resolution limitations; thus, our system represents a suitable alternative to facilitate both observations and quantification.</p><p>Beyond neutrophils, other immune cells, such as monocytes (<xref ref-type="bibr" rid="bib45">McNeil et al., 1994</xref>), macrophages (<xref ref-type="bibr" rid="bib33">Joshi and Saroj, 2023</xref>; <xref ref-type="bibr" rid="bib69">Varin et al., 2010</xref>), and dendritic cells (<xref ref-type="bibr" rid="bib70">Villwock et al., 2008</xref>) respond to <italic>N. meningitis</italic> and their interaction with meningococci can be revisited using our 3D model. For instance, macrophages are activated upon <italic>N. meningitis</italic> infection, eliminate the bacteria through phagocytosis, and produce pro-inflammatory cytokines and chemokines to activate other immune cells (<xref ref-type="bibr" rid="bib33">Joshi and Saroj, 2023</xref>; <xref ref-type="bibr" rid="bib69">Varin et al., 2010</xref>). Also, dendritic cells, uptaking <italic>N. meningitidis</italic>, activate adaptive responses through immune synapse formation with T cells (<xref ref-type="bibr" rid="bib33">Joshi and Saroj, 2023</xref>), but meningococci were also shown to inhibit dendritic cell secretion of proinflammatory cytokines (e.g. TNF-α, IL-1β, IL-6, IL-8) (<xref ref-type="bibr" rid="bib70">Villwock et al., 2008</xref>; <xref ref-type="bibr" rid="bib61">Rhodes et al., 2022</xref>; <xref ref-type="bibr" rid="bib32">Jacobsen et al., 2016</xref>). Such bacterial effects on immune responses, yet complex, would be interesting to study in our model, both because it offers a physiological 3D environment and because it potentially allows us to introduce different human immune cells, including B and T cells, absent in the skin-xenograft mice model.</p><p>To conclude, our Vessel-on-Chip system, which leverages 3D-engineered microenvironments, represents a significant advancement in studying bacterial physiology and pathology in realistic infection contexts. We have demonstrated that our model provides a 3D in vitro platform that recapitulates <italic>N. meningitidis</italic> vascular adhesion and microcolony formation within complex vascular morphologies, as well as the subsequent pathological consequences. Although the system was optimized for meningococcal infection, and given that the vasculature serves as a primary route for systemic infections (<xref ref-type="bibr" rid="bib54">Obino and Duménil, 2019</xref>; <xref ref-type="bibr" rid="bib60">Rahman et al., 2022</xref>) and bacterial dissemination to various organs (<xref ref-type="bibr" rid="bib68">Urbaniak et al., 2014</xref>; <xref ref-type="bibr" rid="bib53">Nejman et al., 2020</xref>), our approach paves the way for investigating the pathophysiological mechanisms triggered by other pathogens responsible for systemic infections (<xref ref-type="bibr" rid="bib1">Alonso-Roman et al., 2024</xref>) (e.g. bacteria, viruses, fungi) in different vascular systems (e.g. capillary beds, arteries) (<xref ref-type="bibr" rid="bib2">Arakawa et al., 2020</xref>). It is also suitable for both quantitative analysis and applied research in the biophysics and biomedical fields, including drug screening and antibiotic resistance studies. By enabling detailed exploration of previously overlooked aspects of infections (e.g. vascular geometry difference, cell specificity, virus/fungi/other bacteria), our model has the potential to advance the development of novel therapeutic strategies to better manage intravascular infections.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Bacteria strains and culture</title><p>Infections were performed using <italic>N. meningitidis</italic> strains derived from the 8013 serogroup C strain (<ext-link ext-link-type="uri" xlink:href="http://www.genoscope.cns.fr/agc/nemesys">http://www.genoscope.cns.fr/agc/nemesys</ext-link>) (<xref ref-type="bibr" rid="bib63">Rusniok et al., 2009</xref>). Mutations in the <italic>pilD</italic> gene have been previously described (<xref ref-type="bibr" rid="bib63">Rusniok et al., 2009</xref>). Wild-type and <italic>pilD</italic> bacterial strains were genetically modified to constitutively express either the green fluorescent protein (GFP) (<xref ref-type="bibr" rid="bib6">Charles-Orszag et al., 2018</xref>), the mScarlet fluorescent protein (mScar), or the near-infrared fluorescent protein (iRFP) under the control of the pilE gene promoter (<xref ref-type="bibr" rid="bib4">Bonazzi et al., 2018</xref>).</p><p>Strains were streaked from –80°C freezer stock onto GCB agar plates and grown overnight (5% CO<sub>2</sub>, 37°C). For all experiments, bacteria were transferred to liquid cultures in pre-warmed RPMI-1640 medium (Gibco) supplemented with 10% FBS at adjusted <inline-formula><alternatives><mml:math id="inf5"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>O</mml:mi><mml:msub><mml:mi>D</mml:mi><mml:mrow><mml:mn>600</mml:mn><mml:mi>n</mml:mi><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft5">\begin{document}$OD_{600nm}$\end{document}</tex-math></alternatives></inline-formula>=0.05 and incubated with gentle agitation for 2 hr at 37°C in the presence of 5% CO<sub>2</sub>.</p><p><italic>Escherichia coli</italic> transformants were grown at 37°C on liquid or solid Luria-Bertani medium (Difco) containing 50 µg/ml kanamycin (for pCR-Blunt II-TOPO plasmid) or 20 µg/ml chloramphenicol plus 100 µg/ml ampicillin (for pMGC5-derived plasmid).</p></sec><sec id="s4-2"><title>pMGC24 construct</title><p>A plasmid allowing stable expression of the mScarlet-I fluorescent protein <xref ref-type="bibr" rid="bib3">Bindels et al., 2017</xref> in <italic>Neisseria meningitidis</italic>, pMGC24, was constructed as follows: the sequence encoding the mScarlet-I fluorescent protein was PCR-amplified from the plasmid pmScarlet-I-C1 (Addgene #85044) with PacI and Xhol restriction sites in 5’ and 3’, respectively using the following primers: PacI_mScar_F: <named-content content-type="sequence"><bold>TTAATTAA</bold><italic>AGGAGTAATTTT</italic>ATGGTGAGCAAGGGCGAG</named-content> and XhoI_mScar_R: <named-content content-type="sequence"><bold>CTCGAG</bold>TTACTTGTACAGCTCGTCCATGC</named-content> (with restriction sites <bold>bolded</bold> and RBS of <italic>pilE</italic> in <italic>italic</italic>). The PCR fragment was then cloned into the pCR-Blunt II-TOPO vector (Invitrogen). After sequencing of the insert, the plasmid was cut with PacI and XhoI, and the resulting fragment was ligated to PacI/XhoI-linearized pMGC5 plasmid (<xref ref-type="bibr" rid="bib67">Soyer et al., 2014</xref>) that allows homologous recombination at an intergenic locus of the <italic>Nm</italic> chromosome and expression under the control of the constitutive <italic>pilE</italic> promoter.</p></sec><sec id="s4-3"><title>Chips production</title><p>The microfluidic chip was designed on Clewin 5.4 (WieWeb software). The corresponding photolithography mask was ordered from Micro Lithography Services LTD (Chelmsford, UK). The chip molds were created using photolithography on an MJB4 mask aligner (Süss MicroTec, Germany). Briefly, SUEX-K200 resin (DJ Microlaminates Inc, US) was laminated onto a 4-inch silicon wafer. Lamination temperature, baking, UV exposure dose, and development steps were performed according to the manufacturer’s recommendations to produce molds with a 200 µm height. Obtained heights were verified with a contact profiler (DektakXT, Bruker). After overnight silanization (Trichloro(1 H,1H,2H,2H-perfluorooctyl)silane, Sigma-Aldrich), replication of the devices was performed with poly-dimethyl-siloxane (PDMS, Silgard 184; Dow Chemical). After polymerization, PDMS slabs were cut and punched to form inlets and outlets (1 and/or 4 mm<sup>2</sup> for lateral channels, 1 mm<sup>2</sup> for central channel). Bonding onto glass-bottom ibidi dishes (Ibidi, #81158) was performed with a Cute plasma cleaner (Femto science, Kr). Critically, assembled microfluidic chips were heated at 80°C for 48 hr to ensure both robust bonding and nominal PDMS hydrophobicity to allow consecutive hydrogel loading.</p><p>Chips were cooled down at 4°C for at least 8 hr to avoid quick polymerization while introducing the hydrogel in the chip. The collagen I solution was introduced in the center channel (see <xref ref-type="fig" rid="fig1">Figure 1</xref>). FujiFilm collagen I (LabChem Wako, Collagen-Gel Culturing Kit) has been used to obtain the 2.4 mg/ml solution, while the high concentration collagen I (Corning, #354249) has been used to obtain the 6 mg/ml, 4 mg/ml, and 3.5 mg/ml solutions according to the manufacturer’s protocol. After collagen polymerization at 37°C for 20 min, PBS (Gibco) was added to the chips via the large lateral channels to avoid hydrogel drying. The inlet and outlet of the hydrogel channel were blocked with a droplet of liquid PDMS. Finally, chips were incubated at 37°C for 30 min to complete the hydrogel polymerization. After 30 min, PDB 1X is added in the chip to avoid gel drying.</p></sec><sec id="s4-4"><title>Photoablation</title><p>We designed the PDMS structures to allow further photoablation carving of 1–3 channels, maximizing the number of vessels that can be imaged while minimizing any loss of permeability at the PDMS/collagen/cells interface. The collagen I matrix was carved using our custom-made photoablation station. Briefly, the microfluidic chip is placed on the stage (SCANPLUS-IM, Marzhauser Wetzlar) of a double-deck microscope (IX81, Evident). A pulsed UV laser (MOPA-355, 500 mW, 10 kHz) is injected into the microscope through a custom-made side port using commercially available optics and opto-mechanical parts (Thorlabs). The laser is then focused within the gel bulk using a 20x objective with NA = 0.7 (UCPLFLN20X). The chip was then displaced with the stage at 1 mm/s to control the ablation region. Laser intensity was checked before each experiment using a light sensor (Thorlabs, Power Sensor Head S170C, and Power Meter for Laser, PM100A). Laser power under the sample was adjusted to 10 mW. The geometries of vessels have been designed with FUSION 360 (AutoCAD) or extracted from intravital microscopy images, exported as a .png binary image, and imported into a Python code. The control of the various elements is embedded and checked for this specific set of hardware. Notably, photoablation is a homemade fabrication technique that can be implemented in any lab equipped with an inverted microscope and a pulsed UV-laser with a repetition rate of around 10 kHz. While the optical setup might require some adjustment, the adaptation would be fairly standard.</p><p>Of note, Corning collagen gels above 6 mg/ml have not been assessed in VoC because they are too viscous and leak from the center channel, and those below 3.5 mg/ml are too liquid to be UV-carved (mechanically unstable). Also, too-high energy alters collagen by forming cavitation bubbles that degrade the scaffold edges, while a too-thin tube will avoid the entry of cells, both making it impossible to use.</p></sec><sec id="s4-5"><title>Chip endothelialisation and use</title><p>Primary human umbilical endothelial cells (HUVECs) were purchased from Lonza (pooled donors, #C2519A) and cultured in EGM-2 complete medium (Lonza, #CC-3162) in untreated 75 cm<sup>2</sup> flasks – 37°C, 5% CO<sub>2</sub>. They were used between passages 2 and 6. Cells have been tested negative to mycoplasma. Before passage or chip endothelialization, HUVECs were detached with 3 mL of Trypsin/EDTA (Gibco) for 4 min at RT. The cell/Trypsin/EDTA suspension was diluted with 4 mL of EGM-2 medium and centrifuged for 5 min at 1200 RPM (<italic>i.e.</italic>, 300 G). After supernatant removal, the cell pellet is diluted to 1/3 for passage and concentrated to 14 × 10<sup>6</sup> cells/mL for chip endothelialization.</p><p>Before endothelialization, chips were washed twice with a warm EGM-2 (with antibiotics) culture medium. The medium was partially removed (to avoid bubbles in the system) and 5 µl of the 14 M cells/mL suspension was introduced in the chip via one lateral channel (see <xref ref-type="fig" rid="fig1">Figure 1</xref>). Chips were then incubated for 30 min at 37°C and 5% CO<sub>2</sub>. The same operation was repeated for the other lateral channel. After 30 more min of incubation, chips were gently washed with EGM-2 medium (with antibiotics) to remove non-adherent cells. Chips were kept at 37°C and 5% CO<sub>2</sub> for 12 hr.</p><p>The flow was added to the setup 12 hr after cell seeding: one inlet and one outlet were closed, syringes (SGE, 2.5 mL, glass) were connected to the inlet (needle: SGE Gastight Syringes, tubings: Tygon – Saint-Gobain, ID 0.02 mm and OD 0.06 mm/PTFE - Merck) and were controlled via a syringe-pump (Cetoni). Because the carved vessels are arranged in parallel (derivation) and the flow is controlled with a syringe pump (<italic>i.e.,</italic> controls directly the flow rate), the flow rate remains the same in each vessel regardless of the number of carved vessels per chip. Microfluidic chips were kept at 37°C - 5% CO<sub>2</sub> for at least 24 hr.</p><p>For TNFα treatment, a solution of 50 ng/mL (Sigma, #H8916) has been introduced in chips for 4 hr (37°C, 5% CO<sub>2</sub>) to induce inflammation on the endothelium.</p><p>For bacterial infection, Vessel-on-Chips were rinsed three times with EGM-2 (without antibiotics) and kept at 37°C and 5% CO<sub>2</sub> overnight. After 2 hr of gentle agitation in EGM-2 (without antibiotics) culture medium as explained above, 10 µl of bacteria solution <inline-formula><alternatives><mml:math id="inf6"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:msub><mml:mrow><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:mrow><mml:mrow><mml:mn>600</mml:mn><mml:mi>n</mml:mi><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft6">\begin{document}${\rm OD}_{600nm}$\end{document}</tex-math></alternatives></inline-formula>=0.05 is introduced in the Vessel-on-Chip. Flow was added to the setup following the description as above explained, during the 3 hr of infection, with a flow rate of 0.5 µl/min.</p></sec><sec id="s4-6"><title>Mice</title><p>SCID/Beige (CB17.Cg-PrkdcscidLystbg-J/Crl) mice were used in all the experiments (Central Animal Facility, Institut Pasteur, Paris, France). Mice were housed under the specific pathogen-free conditions at Institut Pasteur. Mice were kept under standard conditions (light 7 am - 7 pm; temperature 22 ± 1°C; humidity 50 ± 10%) and received sterilized rodent feed and water ad libitum. All experiments were performed in agreement with guidelines established by the French and European regulations for the care and use of laboratory animals and approved by the Institut Pasteur Committee on Animal Welfare (CETEA) under the protocol code CETEA 2018–0022. For all experiments, male and female mice between 6 and 13 weeks of age were used. Littermates were randomly assigned to experimental groups.</p></sec><sec id="s4-7"><title>Xenograft model of infection preparation</title><p>Five to eight weeks old mice, both males and females, were grafted with human skin as previously described (<xref ref-type="bibr" rid="bib47">Melican et al., 2013</xref>). Briefly, a graft bed of about 1 cm<sup>2</sup> was prepared on the flank of anesthetized mice (intraperitoneal injection of ketamine and xylazine at 100 mg/kg and 8.5 mg/kg, respectively) by removing the mouse epithelium and the upper dermis layer. A 200-µm-thick human skin graft comprising the human epidermis and the papillary dermis was immediately placed over the graft bed. Grafts were fixed in place with surgical glue (Vetbond, 3 M, USA) and dressings were applied for 1 week. Grafted mice were used for experimentation 4–10 weeks post-surgery when the human dermal microvasculature is anastomosed to the mouse circulation without evidence of local inflammation, as previously described (<xref ref-type="bibr" rid="bib47">Melican et al., 2013</xref>).</p><p>Normal human skin was obtained from adult patients (20–60 years old), both males and females, undergoing plastic surgery in the service de <italic>Chirurgie Reconstructrice et Plastique</italic> of Groupe Hospitalier Saint Joseph (Paris, France). Following the French legislation, patients were informed and did not refuse to participate in the study. All procedures were approved by the local ethical committee Comité d’Evaluation Ethique de l’INSERM IRB 00003888 FWA 00005881, Paris, France Opinion: 11048.</p><p>Then, intravital imaging of the human xenograft was adapted from <xref ref-type="bibr" rid="bib31">Ho et al., 2000</xref>. Briefly, 30 min before surgery, mice were injected subcutaneously with buprenorphine (0.05 mg/kg) and anesthetized by spontaneous inhalation of isoflurane in 100% oxygen (induction: 4%; maintenance: 1.5% at 0.3 L/min). A middle dorsal incision was made from the neck to the lower back, and the skin supporting the human xenograft was flipped and secured onto an aluminum custom-made heated deck at 36°C. The human microvasculature within the graft was exposed by carefully removing the excess connective tissue. The skin flap was covered with a coverslip and maintained thanks to a 3D-printed custom-made holder to avoid any pressure on the xenograft vasculature, sealed with vacuum grease, and continuously moistened with warmed 1× PBS (36°C). Mice’s hydration was maintained by intraperitoneal injection of 200 µl 0.9% saline solution every hour. During the experiment, the mouse’s body temperature was maintained at 37°C using a heating pad. The tail vein was cannulated, allowing the injection of fluorescent dyes and/or bacteria. In all experiments, human vessels were labeled using fluorescent conjugated UEA-1 lectin (100 µg, Dylight 650 or Dylight 755, Vector Laboratories), and five to ten fields of view of interest containing human vessels were selected per animal for observations.</p></sec><sec id="s4-8"><title>Ear mice preparation</title><p>Mice were anesthetized by spontaneous inhalation of isoflurane in 100% oxygen (induction: 4%; maintenance: 1.5% at 0.3 l/min) and placed in ventral decubitus on a heating pad (37°C) to maintain body temperature. The dorsal face of the ear pinnae was epilated using depilatory cream without causing irritation. The ear was carefully flattened out on an aluminum custom-made heated deck at 36°C and held in place with a coverslip. The tail vein was cannulated, allowing the injection of fluorescent dyes.</p></sec><sec id="s4-9"><title>Immunostaining</title><p>Collagen gels have been stained with a Maleimide Alexa Fluor 488 (Thermo Fisher, #A10254) solution: 10 µl of Maleimide (100 µg/ml) has been diluted within 700 µl of a 0.2 M sodium bicarbonate buffer solution. Chips were incubated with this solution for 1 hr at RT in the dark, and finally gently washed with PBS before imaging.</p><p>For E-selectin experiments, before and after TNFα treatment or bacterial infection, a solution of 10<sup>-3</sup> mg/ml PE-conjugated anti-human E-selectin (CD62E clone P2H3, Thermo Fisher Scientific, #12-0627-42) has been introduced in the chips from the inlets and very little aspired from the outlets, and let for 10 min. After gentle washing steps with EGM-2 medium, E-selectin expression was acquired (Nikon, Spinning disk, Obj. 20X, dry, NA = 0.75).</p><p>Chips were fixed with PFA 4%v/v in PBS for 15 min, permeabilized with Triton X-100 1%v/v in PBS for 30 min, blocked with PBS-gelatin 1%v/v in PBS for 15 min, and mounted with fluoromount-G solution (Fluoromount-G, SouthernBiotech, #0100–01). Chips were incubated with Phalloidin at 0.66 µM (Alexa Fluor 488, Thermofisher, #A12379), anti-human PECAM antibody at 2.5 x 10<sup>-3</sup>mg/ml (Ultra-LEAF Purified anti-human CD31 Antibody, Biolegend #303143 - conjugated with DyLight Antibody Labeling Kits, Thermo Fisher #53044), anti-human collagen IV antibody at 10<sup>-2</sup> mg/ml (Alexa Fluor 642, Clone 1042, eBioscience #51-9871-82), rabbit anti-VE-cadherin (Abcam #ab33168) for 10 hr at 4°C. Alexa Fluor 555-conjugated donkey anti-rabbit antibody (Abcam #ab150074), and Hoechst 10<sup>-2</sup> mg/ml (33362 trihydrochloride trihydrate, Invitrogen #H3570) have been added to the chips after three washing steps with PBS 1X, for 1 hr at room temperature.</p><p>Human and mouse skin samples were fixed with PFA 4% v/v in PBS overnight, washed three times in PBS 1X (30 min of incubation time for each side), and blocked with buffer (0.3% Triton + 1% BSA + 1% NGS in PBS) overnight at 4°C. Samples were stained for 3 days at 4°C with phalloidin (0.66 µM, Alexa Fluor 488, Thermo Fisher, #A12379) and overnight at 4°C with DAPI (0.3 mg/ml, Thermo Fisher, #62247). A sample clearing was made with a Rapid clear 1.47 medium for 2 days at room temperature, and a mounting solution was introduced between the slide and cover slide in rapid clear medium.</p></sec><sec id="s4-10"><title>Permeability assays</title><p>In VoC, 10 µl of a 0.1 mg/mL dextran solution (FITC, Sigma) has been introduced in chips for 30 min. Stacks of four images, spaced 1 µm apart, were acquired every minute.</p><p>In vivo, mice were intravenously injected with 20 µg of anti-mouse CD31 antibodies coupled with Alexa Fluor 647 (clone 390, Biolegend) to label blood vessels and the ear was allowed to stabilize for 30 min. Before imaging, 5 mg of fluorescein isothiocyanate (FITC) conjugated 70 kDa or 150 kDa dextran (Sigma-Aldrich, St Louis, MO) dissolved in 200 µL of phosphate-buffered saline (PBS) were injected intravenously. Stacks of 10 images, spaced 4 µm apart, were acquired every minute.</p><p>For both models, the permeability has been quantified following the equation:<disp-formula id="equ1"><alternatives><mml:math id="m1"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mi>P</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mi>R</mml:mi><mml:mn>2</mml:mn></mml:mfrac><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi><mml:msubsup><mml:mi>I</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow><mml:mrow><mml:mi>c</mml:mi><mml:mi>h</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:mfrac><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msup><mml:mi>I</mml:mi><mml:mrow><mml:mi>c</mml:mi><mml:mi>o</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="t1">\begin{document}$$\displaystyle P = \frac{R}{2}\frac{1}{\Delta I_{0}^{channel}}\frac{dI^{collagen}}{dt}$$\end{document}</tex-math></alternatives></disp-formula></p><p>Where <inline-formula><alternatives><mml:math id="inf7"><mml:mi>R</mml:mi></mml:math><tex-math id="inft7">\begin{document}$R$\end{document}</tex-math></alternatives></inline-formula> is the channel radius, <inline-formula><alternatives><mml:math id="inf8"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi mathvariant="normal">Δ</mml:mi><mml:msubsup><mml:mi>I</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow><mml:mrow><mml:mi>c</mml:mi><mml:mi>h</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msubsup></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft8">\begin{document}$\Delta I_{0}^{channel}$\end{document}</tex-math></alternatives></inline-formula> the first step in increase of fluorescence in the vessel, and <inline-formula><alternatives><mml:math id="inf9"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>d</mml:mi><mml:msup><mml:mi>I</mml:mi><mml:mrow><mml:mi>c</mml:mi><mml:mi>o</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi><mml:mi>a</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msup><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft9">\begin{document}$dI^{collagen}/dt$\end{document}</tex-math></alternatives></inline-formula> the rate of increase in fluorescence outside the vessel.</p><p>Image analysis was conducted over the first 8 min following the initial fluorescence increase within the lumen for both in vivo and VoC models, while the entire acquisition lasted more than 30 min. For each condition, the mean fluorescence intensity was measured inside the vessel and in the surrounding area (background), both before and after introducing fluorescent Dextran. Due to reproducibility constraints in the animal model, only vessels without overlapping background vessels were included in the analysis.</p></sec><sec id="s4-11"><title>Imaging Particle Image Velocity and in vivo Wall Shear Stress</title><p>In vivo, basal microvascular blood flow in human vessels (arterioles and venules) was measured by high-speed acquisitions on a single plane (50 frames per second, 300 frames) of intravenously perfused (15 µl/min) 1 µm large fluorescent microspheres (Yellow/Green Fluoresbrite carboxylate, Polysciences, 107 microspheres/ml 1X PBS). Speed was determined from the centerline microsphere. The blood flow of each vessel was then computed from the vessel surface section and mean velocity following: <inline-formula><alternatives><mml:math id="inf10"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>b</mml:mi><mml:mi>l</mml:mi><mml:mi>o</mml:mi><mml:mi>o</mml:mi><mml:mi>d</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msubsup><mml:mi>V</mml:mi><mml:mrow><mml:mi>b</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msubsup><mml:mo>.</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft10">\begin{document}$Q_{blood}=V_{bead}^{mean}. S_{vessel}$\end{document}</tex-math></alternatives></inline-formula>.</p><p>According to <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>, the flow rate <inline-formula><alternatives><mml:math id="inf11"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>Q</mml:mi></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft11">\begin{document}$Q$\end{document}</tex-math></alternatives></inline-formula> depends on vessel size <inline-formula><alternatives><mml:math id="inf12"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>D</mml:mi></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft12">\begin{document}$D$\end{document}</tex-math></alternatives></inline-formula> as <inline-formula><alternatives><mml:math id="inf13"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mn>1</mml:mn><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:msup><mml:mi>D</mml:mi><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msup></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft13">\begin{document}$1/D^{3}$\end{document}</tex-math></alternatives></inline-formula> (the blue and red fitting curves are <inline-formula><alternatives><mml:math id="inf14"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mn>1</mml:mn><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:msup><mml:mi>x</mml:mi><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msup></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft14">\begin{document}$1/x^{3}$\end{document}</tex-math></alternatives></inline-formula>). Therefore, we can compute the WSS (<inline-formula><alternatives><mml:math id="inf15"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>τ</mml:mi></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft15">\begin{document}$\tau$\end{document}</tex-math></alternatives></inline-formula>) within circular structures following the <xref ref-type="disp-formula" rid="equ2">Equation 1</xref>:<disp-formula id="equ2"><label>(1)</label><alternatives><mml:math id="m2"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mi>τ</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mn>4</mml:mn><mml:mi>η</mml:mi></mml:mrow><mml:mi>π</mml:mi></mml:mfrac><mml:mfrac><mml:mi>Q</mml:mi><mml:msup><mml:mi>R</mml:mi><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msup></mml:mfrac></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="t2">\begin{document}$$\displaystyle \tau=\frac{4\eta}{\pi}\frac{Q}{R^{3}}$$\end{document}</tex-math></alternatives></disp-formula></p><p>where <inline-formula><alternatives><mml:math id="inf16"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>R</mml:mi></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft16">\begin{document}$R$\end{document}</tex-math></alternatives></inline-formula> is the vessel radius, and the viscosity <inline-formula><alternatives><mml:math id="inf17"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>η</mml:mi></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft17">\begin{document}$\eta$\end{document}</tex-math></alternatives></inline-formula> of blood vessel between 25 and 100 µm is considered as constant (<xref ref-type="bibr" rid="bib59">Pries et al., 1995</xref>) (<inline-formula><alternatives><mml:math id="inf18"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>η</mml:mi></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft18">\begin{document}$\eta$\end{document}</tex-math></alternatives></inline-formula>=3.5 × 10<sup>-3</sup> Pa.s at 37°C). The WSS can then be averaged per vessel type (arterioles vs. venules) according to the equation (<xref ref-type="disp-formula" rid="equ2">Equation 1</xref>). The same equation was used to compute the WSS in the Vessel-on-Chip from the flow rate <inline-formula><alternatives><mml:math id="inf19"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>Q</mml:mi></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft19">\begin{document}$Q$\end{document}</tex-math></alternatives></inline-formula>.</p></sec><sec id="s4-12"><title>Neutrophil adhesion and phagocytosis</title><p>For experiments in the VoC, human neutrophils have been purified from donor blood. Human peripheral blood samples were collected from healthy volunteers through the ICAReB-Clin (Clinical Investigation platform) of the Institut Pasteur (<xref ref-type="bibr" rid="bib21">Esterre et al., 2020</xref>). All participants received oral and written information about the research and gave written informed consent in the frame of the healthy volunteers CoSImmGEn cohort (Clinical trials NCT 03925272), after approval of the CPP Ile-de-France I Ethics Committee (2011, Jan 18th) Esterre2020. Neutrophils have been stained for nucleus (Hoechst, 10–3 mg/ml, 33362 trihydrochloride trihydrate, Invitrogen #H3570) and actin (SPY555-actin, 1/1000, Spirochrome #CY-SC202). After 10 min of a TNFα-induced activation (10 ng/mL), 10 µl of a 6.10<sup>6</sup> cells/mL suspension was introduced in the chips under flow. After the flow has been added to the system at 0.7–1 µl/min. Human neutrophil adhesion and phagocytosis have been acquired within 1 hr at 37°C and 5% CO<sub>2</sub>.</p><p>In the animal model, after 2 hr of liquid culture, bacteria were washed twice in PBS and resuspended to 10<sup>8</sup> CFU ml<sup>-1</sup> in PBS. Before infection, mice were injected intraperitoneally with 8 mg of human transferrin (Sigma Aldrich) to promote bacterial growth in vivo, as previously described (<xref ref-type="bibr" rid="bib63">Rusniok et al., 2009</xref>), and neutrophils were labeled by were labeled with 2.5 µg Dylight550-conjugated anti-mouse Ly-6G (LEAF purified anti-mouse Ly-6G, clone 1A8, Biolegend, #127620 with DyLight550 Antibody Labelling Kit, ThermoFisher Scientific, #84530). Mice were infected by intravenous injection of 100 µl of the bacterial inoculum (10<sup>7</sup> CFU total) and time-lapse z-stack series (2–2.5 µm z-step, 50–80 µm range) were captured every 20 min for 3 hr to image bacterial growth and every 30 s for 20 min to image phagocytosis of bacteria by neutrophils.</p><p>Straight channels have been mostly used for all experiments of the study. Rarely, we used the branched in vivo-like designs to observe potential similar infection patterns to in vivo, and related neutrophil activity, without noticing much difference.</p></sec><sec id="s4-13"><title>Rheology assays</title><p>Collagen gel viscoelastic properties were measured using an Ultra + rheometer (Kinexus). 200 µl of collagen gel was placed at the center of the rheometer plate kept at 4°C plate. The 20 mm-diameter testing geometry was lowered to a gap of 200 µm. Excess hydrogel was removed. Temperature was ramped up to 37°C (within 60 s) to initiate the hydrogel formation. Gelation dynamics and gel properties were extracted from continuous geometry rotation at 1 Hz frequency and a 1% strain. Rheological values i.e., elastic modulus G’, stabilized after 200 s. Final values were determined by averaging values between 500 and 700 s.</p></sec><sec id="s4-14"><title>Actin fiber alignment/nucleus alignment and elongation</title><p>The z projection (Maximum Intensity) of the top and bottom parts of vessels has been realized for actin fibers and nucleus segmentation and analysis. Only the images taken with Leica Spinning disk microscope, 40X, NA = 1.10 (see below for more details) were used for analyses. The fibers and the nuclei located at the vessel edges have been excluded from the analysis. The angle and the ratio of major/minor axis have been measured for all vessels (circular plots) and averaged by vessel (dotted graph).</p><p>For in vivo images, the segmentation of nuclei has been achieved by hand for several z-slices for each vessel. The alignment (angle) and elongation (ratio major/minor) have been measured for all vessels (circular plots) and averaged by vessel (dotted graph).</p></sec><sec id="s4-15"><title>In vitro actin recruitment and coherency</title><p>The z projection (Maximum Intensity) of the top and bottom parts of the vessel (taken with the 40X, NA = 1.10 see below for more details) has been used to quantify actin recruitment (ac) and fibers coherency. Region of Interest (ROIs) of similar sizes were located on infected and non-infected areas of the endothelium. For each ROI, the mean fluorescence intensity has been subtracted from the background intensity (collagen matrix) and normalized by the mean of the non-infected areas’ intensity:<disp-formula id="equ3"><alternatives><mml:math id="m3"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:msub><mml:mi>I</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mi>c</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msubsup><mml:mi>I</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>O</mml:mi><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>f</mml:mi><mml:mi>e</mml:mi><mml:mi>c</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi></mml:mrow></mml:msubsup><mml:mo>−</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mrow><mml:mi>b</mml:mi><mml:mi>a</mml:mi><mml:mi>c</mml:mi><mml:mi>k</mml:mi><mml:mi>g</mml:mi><mml:mi>r</mml:mi><mml:mi>o</mml:mi><mml:mi>u</mml:mi><mml:mi>n</mml:mi><mml:mi>d</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msubsup><mml:mi>I</mml:mi><mml:mrow><mml:mi>R</mml:mi><mml:mi>O</mml:mi><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mstyle displaystyle="false" scriptlevel="0"><mml:mtext>-</mml:mtext></mml:mstyle><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>f</mml:mi><mml:mi>e</mml:mi><mml:mi>c</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi></mml:mrow></mml:msubsup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mfrac></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="t3">\begin{document}$$\displaystyle I_{ac} = \frac{I^{infected}_{ROI} - I_{background}} {{mean}(I^{non\mbox{-}infected}_{ROI})}$$\end{document}</tex-math></alternatives></disp-formula></p><p>The coherency has been assessed with the OrientationJ Measure plugin (BIG, EPFL).</p></sec><sec id="s4-16"><title>Simulations</title><p>The shear stress simulations have been performed with COMSOL Multiphysics 6.3. For each vessel, the contour has been segmented with Fiji ImageJ (ImageJ2, version 2.16.0/1.54 g, 26d66057dd), transformed into a binary image, and saved in a vector image (DXF) with Inkscape (Inkscape 1.4, e7c3feb1, 2024-10-09). The DXF file has been used to produce the 2D fluid simulation in COMSOL. Notably, the in vivo-like design must be rotated to allow the upper and lower branches of the complex structure to pass between the fixed PDMS pillars during photoablation. To remain consistent with the image and the flow direction, we have kept the same orientation as in the COMSOL simulation. This leads to a locally higher shear stress at the top of the architecture.</p></sec><sec id="s4-17"><title>Statistics</title><p>Post-processing and statistics analyses have been realized with R (R Studio version 2022.12.0+353, R version 4.2.2 (2022-10-31)). No statistical method was used to predetermine the sample size. Statistical tests were based on the Wilcoxon or t-tests – with <italic>p</italic>-values &gt;0.05: n.s., 0.05&lt;p-values&lt;0.01: *, 0.01&lt;p-values&lt;0.005: **, 0.005&lt;p-values&lt;0.001: ***, <italic>p</italic>-values &lt;0.001: ****. Scatter dot plots show the mean ± sd. Statistical details of experiments, such as sample size, replicate number, and statistical significance, are explicitly added in the figure legends and source data files.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Supervision, Validation, Investigation, Visualization, Methodology, Writing – original draft, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Data curation, Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Resources, Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology</p></fn><fn fn-type="con" id="con4"><p>Conceptualization, Resources, Software, Validation, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Resources, Data curation, Software, Formal analysis, Methodology</p></fn><fn fn-type="con" id="con6"><p>Data curation, Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con7"><p>Data curation, Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con8"><p>Data curation, Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con9"><p>Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con10"><p>Resources, Software, Methodology</p></fn><fn fn-type="con" id="con11"><p>Conceptualization, Data curation, Formal analysis, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con12"><p>Conceptualization, Resources, Software, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Methodology, Writing – original draft, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con13"><p>Conceptualization, Resources, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Writing – original draft, Project administration, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All procedures were approved by the local ethical committee Comité d'Evaluation Ethique de l'INSERM IRB 00003888 FWA 00005881, Paris, France Opinion: 11048.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-107813-mdarchecklist1-v1.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>Data and Python codes are available on gitlab. (<ext-link ext-link-type="uri" xlink:href="https://gitlab.pasteur.fr/wong/photoablationvessel2025">https://gitlab.pasteur.fr/wong/photoablationvessel2025</ext-link>, copy archived at <xref ref-type="bibr" rid="bib73">Wong, 2025</xref>).</p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank P Vargas, A Desys, and M Bernard (Leukomotion, Institut Necker Enfants Malades) for their help in the purification of human neutrophils and C Travaillé (Photonic Bioimaging, Institut Pasteur) for complementary microfluidic chip imaging. We are grateful to the healthy volunteers of blood donation, for their participation in the study. We thank ICAReB-Clin of the Medical Direction and ICAReB-biobank of the CRBIP (BioResource Center) of the Institut Pasteur (Paris) for providing blood samples from healthy volunteers. To H Laude, L Arowas, B L Perlaza, A Z M Delhaye and C Noury for managing the participants’ visits. To E Roux, R Artus, L Sangari, D Cheval, and S Vacant for preparing the blood samples from donors. Funding was obtained by GD from the Fondation pour la Recherche Médicale (EQU202203014610), the DESTOP European Research Council (ERC) Advanced grant, the Fondation NRJ, and the ‘Integrative Biology of Emerging Infectious Diseases’ Labex (ANR 10-LBX-62 IBEID). Funding was obtained by GD and SG from the The Association Nationale pour la Recherche (ANR MeningoChip 18-CE15-0006-01). This work was also supported by DIM ELICIT’s grant from Région Ile-de-France, obtained by SG.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alonso-Roman</surname><given-names>R</given-names></name><name><surname>Mosig</surname><given-names>AS</given-names></name><name><surname>Figge</surname><given-names>MT</given-names></name><name><surname>Papenfort</surname><given-names>K</given-names></name><name><surname>Eggeling</surname><given-names>C</given-names></name><name><surname>Schacher</surname><given-names>FH</given-names></name><name><surname>Hube</surname><given-names>B</given-names></name><name><surname>Gresnigt</surname><given-names>MS</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Organ-on-chip models for infectious disease research</article-title><source>Nature Microbiology</source><volume>9</volume><fpage>891</fpage><lpage>904</lpage><pub-id pub-id-type="doi">10.1038/s41564-024-01645-6</pub-id><pub-id pub-id-type="pmid">38528150</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arakawa</surname><given-names>C</given-names></name><name><surname>Gunnarsson</surname><given-names>C</given-names></name><name><surname>Howard</surname><given-names>C</given-names></name><name><surname>Bernabeu</surname><given-names>M</given-names></name><name><surname>Phong</surname><given-names>K</given-names></name><name><surname>Yang</surname><given-names>E</given-names></name><name><surname>DeForest</surname><given-names>CA</given-names></name><name><surname>Smith</surname><given-names>JD</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Biophysical and biomolecular interactions of malaria-infected erythrocytes in engineered human capillaries</article-title><source>Science Advances</source><volume>6</volume><elocation-id>eaay7243</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.aay7243</pub-id><pub-id pub-id-type="pmid">32010773</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bindels</surname><given-names>DS</given-names></name><name><surname>Haarbosch</surname><given-names>L</given-names></name><name><surname>van Weeren</surname><given-names>L</given-names></name><name><surname>Postma</surname><given-names>M</given-names></name><name><surname>Wiese</surname><given-names>KE</given-names></name><name><surname>Mastop</surname><given-names>M</given-names></name><name><surname>Aumonier</surname><given-names>S</given-names></name><name><surname>Gotthard</surname><given-names>G</given-names></name><name><surname>Royant</surname><given-names>A</given-names></name><name><surname>Hink</surname><given-names>MA</given-names></name><name><surname>Gadella</surname><given-names>TWJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>mScarlet: a bright monomeric red fluorescent protein for cellular imaging</article-title><source>Nature Methods</source><volume>14</volume><fpage>53</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1038/nmeth.4074</pub-id><pub-id pub-id-type="pmid">27869816</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonazzi</surname><given-names>D</given-names></name><name><surname>Lo Schiavo</surname><given-names>V</given-names></name><name><surname>Machata</surname><given-names>S</given-names></name><name><surname>Djafer-Cherif</surname><given-names>I</given-names></name><name><surname>Nivoit</surname><given-names>P</given-names></name><name><surname>Manriquez</surname><given-names>V</given-names></name><name><surname>Tanimoto</surname><given-names>H</given-names></name><name><surname>Husson</surname><given-names>J</given-names></name><name><surname>Henry</surname><given-names>N</given-names></name><name><surname>Chaté</surname><given-names>H</given-names></name><name><surname>Voituriez</surname><given-names>R</given-names></name><name><surname>Duménil</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Intermittent pili-mediated forces fluidize <italic>Neisseria meningitidis</italic> aggregates promoting vascular colonization</article-title><source>Cell</source><volume>174</volume><fpage>143</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.04.010</pub-id><pub-id pub-id-type="pmid">29779947</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brandenberg</surname><given-names>N</given-names></name><name><surname>Lutolf</surname><given-names>MP</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>In situ patterning of microfluidic networks in 3D cell-laden hydrogels</article-title><source>Advanced Materials</source><volume>28</volume><fpage>7450</fpage><lpage>7456</lpage><pub-id pub-id-type="doi">10.1002/adma.201601099</pub-id><pub-id pub-id-type="pmid">27334545</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charles-Orszag</surname><given-names>A</given-names></name><name><surname>Tsai</surname><given-names>F-C</given-names></name><name><surname>Bonazzi</surname><given-names>D</given-names></name><name><surname>Manriquez</surname><given-names>V</given-names></name><name><surname>Sachse</surname><given-names>M</given-names></name><name><surname>Mallet</surname><given-names>A</given-names></name><name><surname>Salles</surname><given-names>A</given-names></name><name><surname>Melican</surname><given-names>K</given-names></name><name><surname>Staneva</surname><given-names>R</given-names></name><name><surname>Bertin</surname><given-names>A</given-names></name><name><surname>Millien</surname><given-names>C</given-names></name><name><surname>Goussard</surname><given-names>S</given-names></name><name><surname>Lafaye</surname><given-names>P</given-names></name><name><surname>Shorte</surname><given-names>S</given-names></name><name><surname>Piel</surname><given-names>M</given-names></name><name><surname>Krijnse-Locker</surname><given-names>J</given-names></name><name><surname>Brochard-Wyart</surname><given-names>F</given-names></name><name><surname>Bassereau</surname><given-names>P</given-names></name><name><surname>Duménil</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Adhesion to nanofibers drives cell membrane remodeling through one-dimensional wetting</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>4450</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-06948-x</pub-id><pub-id pub-id-type="pmid">30361638</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Corre</surname><given-names>JP</given-names></name><name><surname>Obino</surname><given-names>D</given-names></name><name><surname>Nivoit</surname><given-names>P</given-names></name><name><surname>Yatim</surname><given-names>A</given-names></name><name><surname>Schmitt</surname><given-names>T</given-names></name><name><surname>Duménil</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Anti-thrombotic treatment enhances antibiotic efficiency in a humanized model of meningococcemia</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2022.01.10.475613</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Craig</surname><given-names>L</given-names></name><name><surname>Forest</surname><given-names>KT</given-names></name><name><surname>Maier</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Type IV pili: dynamics, biophysics and functional consequences</article-title><source>Nature Reviews. Microbiology</source><volume>17</volume><fpage>429</fpage><lpage>440</lpage><pub-id pub-id-type="doi">10.1038/s41579-019-0195-4</pub-id><pub-id pub-id-type="pmid">30988511</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>PF</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Flow-mediated endothelial mechanotransduction</article-title><source>Physiological Reviews</source><volume>75</volume><fpage>519</fpage><lpage>560</lpage><pub-id pub-id-type="doi">10.1152/physrev.1995.75.3.519</pub-id><pub-id pub-id-type="pmid">7624393</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>PF</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology</article-title><source>Nature Clinical Practice. Cardiovascular Medicine</source><volume>6</volume><fpage>16</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1038/ncpcardio1397</pub-id><pub-id pub-id-type="pmid">19029993</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>GE</given-names></name><name><surname>Senger</surname><given-names>DR</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Endothelial Extracellular Matrix</article-title><source>Circulation Research</source><volume>97</volume><fpage>1093</fpage><lpage>1107</lpage><pub-id pub-id-type="doi">10.1161/01.RES.0000191547.64391.e3</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denis</surname><given-names>K</given-names></name><name><surname>Le Bris</surname><given-names>M</given-names></name><name><surname>Le Guennec</surname><given-names>L</given-names></name><name><surname>Barnier</surname><given-names>J-P</given-names></name><name><surname>Faure</surname><given-names>C</given-names></name><name><surname>Gouge</surname><given-names>A</given-names></name><name><surname>Bouzinba-Ségard</surname><given-names>H</given-names></name><name><surname>Jamet</surname><given-names>A</given-names></name><name><surname>Euphrasie</surname><given-names>D</given-names></name><name><surname>Durel</surname><given-names>B</given-names></name><name><surname>Barois</surname><given-names>N</given-names></name><name><surname>Pelissier</surname><given-names>P</given-names></name><name><surname>Morand</surname><given-names>PC</given-names></name><name><surname>Coureuil</surname><given-names>M</given-names></name><name><surname>Lafont</surname><given-names>F</given-names></name><name><surname>Join-Lambert</surname><given-names>O</given-names></name><name><surname>Nassif</surname><given-names>X</given-names></name><name><surname>Bourdoulous</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Targeting Type IV pili as an antivirulence strategy against invasive meningococcal disease</article-title><source>Nature Microbiology</source><volume>4</volume><fpage>972</fpage><lpage>984</lpage><pub-id pub-id-type="doi">10.1038/s41564-019-0395-8</pub-id><pub-id pub-id-type="pmid">30911127</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dessalles</surname><given-names>CA</given-names></name><name><surname>Ramón-Lozano</surname><given-names>C</given-names></name><name><surname>Babataheri</surname><given-names>A</given-names></name><name><surname>Barakat</surname><given-names>AI</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Luminal flow actuation generates coupled shear and strain in a microvessel-on-chip</article-title><source>Biofabrication</source><volume>14</volume><elocation-id>015003</elocation-id><pub-id pub-id-type="doi">10.1088/1758-5090/ac2baa</pub-id><pub-id pub-id-type="pmid">34592728</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doulet</surname><given-names>N</given-names></name><name><surname>Donnadieu</surname><given-names>E</given-names></name><name><surname>Laran-Chich</surname><given-names>MP</given-names></name><name><surname>Niedergang</surname><given-names>F</given-names></name><name><surname>Nassif</surname><given-names>X</given-names></name><name><surname>Couraud</surname><given-names>PO</given-names></name><name><surname>Bourdoulous</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title><italic>Neisseria meningitidis</italic> infection of human endothelial cells interferes with leukocyte transmigration by preventing the formation of endothelial docking structures</article-title><source>The Journal of Cell Biology</source><volume>173</volume><fpage>627</fpage><lpage>637</lpage><pub-id pub-id-type="doi">10.1083/jcb.200507128</pub-id><pub-id pub-id-type="pmid">16717131</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dudley</surname><given-names>AC</given-names></name><name><surname>Griffioen</surname><given-names>AW</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>The modes of angiogenesis: an updated perspective</article-title><source>Angiogenesis</source><volume>26</volume><fpage>477</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1007/s10456-023-09895-4</pub-id><pub-id pub-id-type="pmid">37640982</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egawa</surname><given-names>G</given-names></name><name><surname>Nakamizo</surname><given-names>S</given-names></name><name><surname>Natsuaki</surname><given-names>Y</given-names></name><name><surname>Doi</surname><given-names>H</given-names></name><name><surname>Miyachi</surname><given-names>Y</given-names></name><name><surname>Kabashima</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Intravital analysis of vascular permeability in mice using two-photon microscopy</article-title><source>Scientific Reports</source><volume>3</volume><elocation-id>1932</elocation-id><pub-id pub-id-type="doi">10.1038/srep01932</pub-id><pub-id pub-id-type="pmid">23732999</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Endres</surname><given-names>LM</given-names></name><name><surname>Jungblut</surname><given-names>M</given-names></name><name><surname>Divyapicigil</surname><given-names>M</given-names></name><name><surname>Sauer</surname><given-names>M</given-names></name><name><surname>Stigloher</surname><given-names>C</given-names></name><name><surname>Christodoulides</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>BJ</given-names></name><name><surname>Schubert-Unkmeir</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Development of a multicellular in vitro model of the meningeal blood-CSF barrier to study <italic>Neisseria meningitidis</italic> infection</article-title><source>Fluids and Barriers of the CNS</source><volume>19</volume><elocation-id>81</elocation-id><pub-id pub-id-type="doi">10.1186/s12987-022-00379-z</pub-id><pub-id pub-id-type="pmid">36289516</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enrico</surname><given-names>A</given-names></name><name><surname>Voulgaris</surname><given-names>D</given-names></name><name><surname>Östmans</surname><given-names>R</given-names></name><name><surname>Sundaravadivel</surname><given-names>N</given-names></name><name><surname>Moutaux</surname><given-names>L</given-names></name><name><surname>Cordier</surname><given-names>A</given-names></name><name><surname>Niklaus</surname><given-names>F</given-names></name><name><surname>Herland</surname><given-names>A</given-names></name><name><surname>Stemme</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>3D Microvascularized tissue models by laser-based cavitation molding of collagen</article-title><source>Advanced Materials</source><volume>34</volume><elocation-id>e2109823</elocation-id><pub-id pub-id-type="doi">10.1002/adma.202109823</pub-id><pub-id pub-id-type="pmid">35029309</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eriksson</surname><given-names>J</given-names></name><name><surname>Eriksson</surname><given-names>OS</given-names></name><name><surname>Maudsdotter</surname><given-names>L</given-names></name><name><surname>Palm</surname><given-names>O</given-names></name><name><surname>Engman</surname><given-names>J</given-names></name><name><surname>Sarkissian</surname><given-names>T</given-names></name><name><surname>Aro</surname><given-names>H</given-names></name><name><surname>Wallin</surname><given-names>M</given-names></name><name><surname>Jonsson</surname><given-names>AB</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Characterization of motility and piliation in pathogenic Neisseria</article-title><source>BMC Microbiology</source><volume>15</volume><elocation-id>92</elocation-id><pub-id pub-id-type="doi">10.1186/s12866-015-0424-6</pub-id><pub-id pub-id-type="pmid">25925502</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ershov</surname><given-names>D</given-names></name><name><surname>Phan</surname><given-names>M-S</given-names></name><name><surname>Pylvänäinen</surname><given-names>JW</given-names></name><name><surname>Rigaud</surname><given-names>SU</given-names></name><name><surname>Le Blanc</surname><given-names>L</given-names></name><name><surname>Charles-Orszag</surname><given-names>A</given-names></name><name><surname>Conway</surname><given-names>JRW</given-names></name><name><surname>Laine</surname><given-names>RF</given-names></name><name><surname>Roy</surname><given-names>NH</given-names></name><name><surname>Bonazzi</surname><given-names>D</given-names></name><name><surname>Duménil</surname><given-names>G</given-names></name><name><surname>Jacquemet</surname><given-names>G</given-names></name><name><surname>Tinevez</surname><given-names>J-Y</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>TrackMate 7: integrating state-of-the-art segmentation algorithms into tracking pipelines</article-title><source>Nature Methods</source><volume>19</volume><fpage>829</fpage><lpage>832</lpage><pub-id pub-id-type="doi">10.1038/s41592-022-01507-1</pub-id><pub-id pub-id-type="pmid">35654950</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esterre</surname><given-names>P</given-names></name><name><surname>Ait-Saadi</surname><given-names>A</given-names></name><name><surname>Arowas</surname><given-names>L</given-names></name><name><surname>Chaouche</surname><given-names>S</given-names></name><name><surname>Corre-Catelin</surname><given-names>N</given-names></name><name><surname>Fanaud</surname><given-names>C</given-names></name><name><surname>Laude</surname><given-names>H</given-names></name><name><surname>Mellon</surname><given-names>V</given-names></name><name><surname>Monceaux</surname><given-names>V</given-names></name><name><surname>Morizot</surname><given-names>G</given-names></name><name><surname>Najjar</surname><given-names>I</given-names></name><name><surname>Ottone</surname><given-names>C</given-names></name><name><surname>Perlaza</surname><given-names>BL</given-names></name><name><surname>Rimbault</surname><given-names>B</given-names></name><name><surname>Sangari</surname><given-names>L</given-names></name><name><surname>Ungeheuer</surname><given-names>MN</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The ICAReB Platform: a human biobank for the institut pasteur and beyond</article-title><source>Open Journal of Bioresources</source><volume>7</volume><elocation-id>66</elocation-id><pub-id pub-id-type="doi">10.5334/ojb.66</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eugène</surname><given-names>E</given-names></name><name><surname>Hoffmann</surname><given-names>I</given-names></name><name><surname>Pujol</surname><given-names>C</given-names></name><name><surname>Couraud</surname><given-names>P-O</given-names></name><name><surname>Bourdoulous</surname><given-names>S</given-names></name><name><surname>Nassif</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Microvilli-like structures are associated with the internalization of virulent capsulated <italic>Neisseria meningitidis</italic> into vascular endothelial cells</article-title><source>Journal of Cell Science</source><volume>115</volume><fpage>1231</fpage><lpage>1241</lpage><pub-id pub-id-type="doi">10.1242/jcs.115.6.1231</pub-id><pub-id pub-id-type="pmid">11884522</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faust</surname><given-names>SN</given-names></name><name><surname>Heyderman</surname><given-names>RS</given-names></name><name><surname>Levin</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Disseminated intravascular coagulation and purpura fulminans secondary to infection</article-title><source>Best Practice &amp; Research Clinical Haematology</source><volume>13</volume><fpage>179</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1053/beha.2000.0067</pub-id><pub-id pub-id-type="pmid">10942620</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Han</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Duan</surname><given-names>X</given-names></name><name><surname>Xie</surname><given-names>W</given-names></name><name><surname>Tian</surname><given-names>Z</given-names></name><name><surname>Yuan</surname><given-names>Z</given-names></name><name><surname>Wan</surname><given-names>Z</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Qin</surname><given-names>S</given-names></name><name><surname>He</surname><given-names>K</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Geometric constraint-triggered collagen expression mediates bacterial-host adhesion</article-title><source>Nature Communications</source><volume>14</volume><elocation-id>8165</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-023-43827-6</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franca</surname><given-names>CM</given-names></name><name><surname>Lima Verde</surname><given-names>ME</given-names></name><name><surname>Silva-Sousa</surname><given-names>AC</given-names></name><name><surname>Mansoorifar</surname><given-names>A</given-names></name><name><surname>Athirasala</surname><given-names>A</given-names></name><name><surname>Subbiah</surname><given-names>R</given-names></name><name><surname>Tahayeri</surname><given-names>A</given-names></name><name><surname>Sousa</surname><given-names>M</given-names></name><name><surname>Fraga</surname><given-names>MA</given-names></name><name><surname>Visalakshan</surname><given-names>RM</given-names></name><name><surname>Doe</surname><given-names>A</given-names></name><name><surname>Beadle</surname><given-names>K</given-names></name><name><surname>Finley</surname><given-names>M</given-names></name><name><surname>Dimitriadis</surname><given-names>E</given-names></name><name><surname>Bays</surname><given-names>J</given-names></name><name><surname>Uroz</surname><given-names>M</given-names></name><name><surname>Yamada</surname><given-names>KM</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Bertassoni</surname><given-names>LE</given-names></name></person-group><year iso-8601-date="2025">2025</year><article-title>Perivascular cells function as key mediators of mechanical and structural changes in vascular capillaries</article-title><source>Science Advances</source><volume>11</volume><elocation-id>eadp3789</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.adp3789</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guarner</surname><given-names>J</given-names></name><name><surname>Greer</surname><given-names>PW</given-names></name><name><surname>Whitney</surname><given-names>A</given-names></name><name><surname>Shieh</surname><given-names>W-J</given-names></name><name><surname>Fischer</surname><given-names>M</given-names></name><name><surname>White</surname><given-names>EH</given-names></name><name><surname>Carlone</surname><given-names>GM</given-names></name><name><surname>Stephens</surname><given-names>DS</given-names></name><name><surname>Popovic</surname><given-names>T</given-names></name><name><surname>Zaki</surname><given-names>SR</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Pathogenesis and diagnosis of human meningococcal disease using immunohistochemical and PCR assays</article-title><source>American Journal of Clinical Pathology</source><volume>122</volume><fpage>754</fpage><lpage>764</lpage><pub-id pub-id-type="doi">10.1309/A7M2-FN2T-YE6A-8UFX</pub-id><pub-id pub-id-type="pmid">15491972</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haase</surname><given-names>K</given-names></name><name><surname>Kamm</surname><given-names>RD</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Advances in on-chip vascularization</article-title><source>Regenerative Medicine</source><volume>12</volume><fpage>285</fpage><lpage>302</lpage><pub-id pub-id-type="doi">10.2217/rme-2016-0152</pub-id><pub-id pub-id-type="pmid">28318376</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haase</surname><given-names>K</given-names></name><name><surname>Offeddu</surname><given-names>GS</given-names></name><name><surname>Gillrie</surname><given-names>MR</given-names></name><name><surname>Kamm</surname><given-names>RD</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Endothelial regulation of drug transport in a 3D vascularized tumor model</article-title><source>Advanced Functional Materials</source><volume>30</volume><elocation-id>2002444</elocation-id><pub-id pub-id-type="doi">10.1002/adfm.202002444</pub-id><pub-id pub-id-type="pmid">33692661</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haase</surname><given-names>K</given-names></name><name><surname>Piatti</surname><given-names>F</given-names></name><name><surname>Marcano</surname><given-names>M</given-names></name><name><surname>Shin</surname><given-names>Y</given-names></name><name><surname>Visone</surname><given-names>R</given-names></name><name><surname>Redaelli</surname><given-names>A</given-names></name><name><surname>Rasponi</surname><given-names>M</given-names></name><name><surname>Kamm</surname><given-names>RD</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Physiologic flow-conditioning limits vascular dysfunction in engineered human capillaries</article-title><source>Biomaterials</source><volume>280</volume><elocation-id>121248</elocation-id><pub-id pub-id-type="doi">10.1016/j.biomaterials.2021.121248</pub-id><pub-id pub-id-type="pmid">34794827</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herland</surname><given-names>A</given-names></name><name><surname>van der Meer</surname><given-names>AD</given-names></name><name><surname>FitzGerald</surname><given-names>EA</given-names></name><name><surname>Park</surname><given-names>TE</given-names></name><name><surname>Sleeboom</surname><given-names>JJF</given-names></name><name><surname>Ingber</surname><given-names>DE</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Distinct contributions of astrocytes and pericytes to neuroinflammation identified in a 3D Human Blood-Brain Barrier on a Chip</article-title><source>PLOS ONE</source><volume>11</volume><elocation-id>e0150360</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0150360</pub-id><pub-id pub-id-type="pmid">26930059</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>M</given-names></name><name><surname>Hickey</surname><given-names>MJ</given-names></name><name><surname>Murray</surname><given-names>AG</given-names></name><name><surname>Andonegui</surname><given-names>G</given-names></name><name><surname>Kubes</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Visualization of <italic>Plasmodium falciparum</italic>-endothelium interactions in human microvasculature: mimicry of leukocyte recruitment</article-title><source>The Journal of Experimental Medicine</source><volume>192</volume><fpage>1205</fpage><lpage>1211</lpage><pub-id pub-id-type="doi">10.1084/jem.192.8.1205</pub-id><pub-id pub-id-type="pmid">11034611</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacobsen</surname><given-names>MC</given-names></name><name><surname>Dusart</surname><given-names>PJ</given-names></name><name><surname>Kotowicz</surname><given-names>K</given-names></name><name><surname>Bajaj-Elliott</surname><given-names>M</given-names></name><name><surname>Hart</surname><given-names>SL</given-names></name><name><surname>Klein</surname><given-names>NJ</given-names></name><name><surname>Dixon</surname><given-names>GL</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A critical role for ATF2 transcription factor in the regulation of E-selectin expression in response to non-endotoxin components of <italic>Neisseria meningitidis</italic></article-title><source>Cellular Microbiology</source><volume>18</volume><fpage>66</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1111/cmi.12483</pub-id><pub-id pub-id-type="pmid">26153406</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joshi</surname><given-names>R</given-names></name><name><surname>Saroj</surname><given-names>SD</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Survival and evasion of <italic>Neisseria meningitidis</italic> from macrophages</article-title><source>Medicine in Microecology</source><volume>17</volume><elocation-id>100087</elocation-id><pub-id pub-id-type="doi">10.1016/j.medmic.2023.100087</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><name><surname>Chung</surname><given-names>M</given-names></name><name><surname>Jeon</surname><given-names>NL</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Engineering of functional, perfusable 3D microvascular networks on a chip</article-title><source>Lab on a Chip</source><volume>13</volume><fpage>1489</fpage><lpage>1500</lpage><pub-id pub-id-type="doi">10.1039/c3lc41320a</pub-id><pub-id pub-id-type="pmid">23440068</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ko</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>Y</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>SR</given-names></name><name><surname>Jeon</surname><given-names>NL</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Human ocular angiogenesis-inspired vascular models on an injection-molded microfluidic chip</article-title><source>Advanced Healthcare Materials</source><volume>8</volume><elocation-id>e1900328</elocation-id><pub-id pub-id-type="doi">10.1002/adhm.201900328</pub-id><pub-id pub-id-type="pmid">31199057</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobsar</surname><given-names>A</given-names></name><name><surname>Siauw</surname><given-names>C</given-names></name><name><surname>Gambaryan</surname><given-names>S</given-names></name><name><surname>Hebling</surname><given-names>S</given-names></name><name><surname>Speer</surname><given-names>C</given-names></name><name><surname>Schubert-Unkmeir</surname><given-names>A</given-names></name><name><surname>Eigenthaler</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title><italic>Neisseria meningitidis</italic> induces platelet inhibition and increases vascular endothelial permeability via nitric oxide regulated pathways</article-title><source>Thrombosis and Haemostasis</source><volume>106</volume><fpage>1127</fpage><lpage>1138</lpage><pub-id pub-id-type="doi">10.1160/TH11-07-0491</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leclech</surname><given-names>C</given-names></name><name><surname>Natale</surname><given-names>CF</given-names></name><name><surname>Barakat</surname><given-names>AI</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The basement membrane as a structured surface - role in vascular health and disease</article-title><source>Journal of Cell Science</source><volume>133</volume><elocation-id>jcs239889</elocation-id><pub-id pub-id-type="doi">10.1242/jcs.239889</pub-id><pub-id pub-id-type="pmid">32938688</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Jin</surname><given-names>SP</given-names></name><name><surname>Kim</surname><given-names>YK</given-names></name><name><surname>Sung</surname><given-names>GY</given-names></name><name><surname>Chung</surname><given-names>JH</given-names></name><name><surname>Sung</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Construction of 3D multicellular microfluidic chip for an in vitro skin model</article-title><source>Biomedical Microdevices</source><volume>19</volume><elocation-id>22</elocation-id><pub-id pub-id-type="doi">10.1007/s10544-017-0156-5</pub-id><pub-id pub-id-type="pmid">28374277</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ley</surname><given-names>K</given-names></name><name><surname>Laudanna</surname><given-names>C</given-names></name><name><surname>Cybulsky</surname><given-names>MI</given-names></name><name><surname>Nourshargh</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Getting to the site of inflammation: the leukocyte adhesion cascade updated</article-title><source>Nature Reviews. Immunology</source><volume>7</volume><fpage>678</fpage><lpage>689</lpage><pub-id pub-id-type="doi">10.1038/nri2156</pub-id><pub-id pub-id-type="pmid">17717539</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Zhu</surname><given-names>K</given-names></name><name><surname>Duan</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>Han</surname><given-names>Y</given-names></name><name><surname>Peng</surname><given-names>W</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Extracellular matrix stiffness modulates host-bacteria interactions and antibiotic therapy of bacterial internalization</article-title><source>Biomaterials</source><volume>277</volume><elocation-id>121098</elocation-id><pub-id pub-id-type="doi">10.1016/j.biomaterials.2021.121098</pub-id><pub-id pub-id-type="pmid">34478931</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname><given-names>RKM</given-names></name><name><surname>Korbmacher</surname><given-names>F</given-names></name><name><surname>Ronchi</surname><given-names>P</given-names></name><name><surname>Fleckenstein</surname><given-names>H</given-names></name><name><surname>Schorb</surname><given-names>M</given-names></name><name><surname>Mirza</surname><given-names>W</given-names></name><name><surname>Mallorquí</surname><given-names>M</given-names></name><name><surname>Aguilar</surname><given-names>R</given-names></name><name><surname>Moncunill</surname><given-names>G</given-names></name><name><surname>Schwab</surname><given-names>Y</given-names></name><name><surname>Bernabeu</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2025">2025</year><article-title><italic>Plasmodium falciparum</italic> impairs Ang-1 secretion by pericytes in a 3D brain microvessel model</article-title><source>EMBO Molecular Medicine</source><volume>17</volume><fpage>3110</fpage><lpage>3138</lpage><pub-id pub-id-type="doi">10.1038/s44321-025-00319-y</pub-id><pub-id pub-id-type="pmid">41102495</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mairey</surname><given-names>E</given-names></name><name><surname>Genovesio</surname><given-names>A</given-names></name><name><surname>Donnadieu</surname><given-names>E</given-names></name><name><surname>Bernard</surname><given-names>C</given-names></name><name><surname>Jaubert</surname><given-names>F</given-names></name><name><surname>Pinard</surname><given-names>E</given-names></name><name><surname>Seylaz</surname><given-names>J</given-names></name><name><surname>Olivo-Marin</surname><given-names>J-C</given-names></name><name><surname>Nassif</surname><given-names>X</given-names></name><name><surname>Duménil</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Cerebral microcirculation shear stress levels determine <italic>Neisseria meningitidis</italic> attachment sites along the blood-brain barrier</article-title><source>The Journal of Experimental Medicine</source><volume>203</volume><fpage>1939</fpage><lpage>1950</lpage><pub-id pub-id-type="doi">10.1084/jem.20060482</pub-id><pub-id pub-id-type="pmid">16864659</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malek</surname><given-names>AM</given-names></name><name><surname>Izumo</surname><given-names>S</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Mechanism of endothelial cell shape change and cytoskeletal remodeling in response to fluid shear stress</article-title><source>Journal of Cell Science</source><volume>109 ( Pt 4)</volume><fpage>713</fpage><lpage>726</lpage><pub-id pub-id-type="doi">10.1242/jcs.109.4.713</pub-id><pub-id pub-id-type="pmid">8718663</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manriquez</surname><given-names>V</given-names></name><name><surname>Nivoit</surname><given-names>P</given-names></name><name><surname>Urbina</surname><given-names>T</given-names></name><name><surname>Echenique-Rivera</surname><given-names>H</given-names></name><name><surname>Melican</surname><given-names>K</given-names></name><name><surname>Fernandez-Gerlinger</surname><given-names>M-P</given-names></name><name><surname>Flamant</surname><given-names>P</given-names></name><name><surname>Schmitt</surname><given-names>T</given-names></name><name><surname>Bruneval</surname><given-names>P</given-names></name><name><surname>Obino</surname><given-names>D</given-names></name><name><surname>Duménil</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Colonization of dermal arterioles by <italic>Neisseria meningitidis</italic> provides a safe haven from neutrophils</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>4547</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-24797-z</pub-id><pub-id pub-id-type="pmid">34315900</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNeil</surname><given-names>G</given-names></name><name><surname>Virji</surname><given-names>M</given-names></name><name><surname>Moxon</surname><given-names>ER</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Interactions of <italic>Neisseria meningitidis</italic> with human monocytes</article-title><source>Microbial Pathogenesis</source><volume>16</volume><fpage>153</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1006/mpat.1994.1016</pub-id><pub-id pub-id-type="pmid">7913984</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melican</surname><given-names>K</given-names></name><name><surname>Dumenil</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Vascular colonization by <italic>Neisseria meningitidis</italic></article-title><source>Current Opinion in Microbiology</source><volume>15</volume><fpage>50</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1016/j.mib.2011.10.008</pub-id><pub-id pub-id-type="pmid">22185907</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melican</surname><given-names>K</given-names></name><name><surname>Michea Veloso</surname><given-names>P</given-names></name><name><surname>Martin</surname><given-names>T</given-names></name><name><surname>Bruneval</surname><given-names>P</given-names></name><name><surname>Duménil</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Adhesion of <italic>Neisseria meningitidis</italic> to dermal vessels leads to local vascular damage and purpura in a humanized mouse model</article-title><source>PLOS Pathogens</source><volume>9</volume><elocation-id>e1003139</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1003139</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merz</surname><given-names>AJ</given-names></name><name><surname>So</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Attachment of piliated, Opa- and Opc- gonococci and meningococci to epithelial cells elicits cortical actin rearrangements and clustering of tyrosine-phosphorylated proteins</article-title><source>Infection and Immunity</source><volume>65</volume><fpage>4341</fpage><lpage>4349</lpage><pub-id pub-id-type="doi">10.1128/iai.65.10.4341-4349.1997</pub-id><pub-id pub-id-type="pmid">9317047</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merz</surname><given-names>AJ</given-names></name><name><surname>Enns</surname><given-names>CA</given-names></name><name><surname>So</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Type IV pili of pathogenic Neisseriae elicit cortical plaque formation in epithelial cells</article-title><source>Molecular Microbiology</source><volume>32</volume><fpage>1316</fpage><lpage>1332</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2958.1999.01459.x</pub-id><pub-id pub-id-type="pmid">10383771</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Middelkamp</surname><given-names>HHT</given-names></name><name><surname>Weener</surname><given-names>HJ</given-names></name><name><surname>Gensheimer</surname><given-names>T</given-names></name><name><surname>Vermeul</surname><given-names>K</given-names></name><name><surname>de Heus</surname><given-names>LE</given-names></name><name><surname>Albers</surname><given-names>HJ</given-names></name><name><surname>van den Berg</surname><given-names>A</given-names></name><name><surname>van der Meer</surname><given-names>AD</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Embedded macrophages induce intravascular coagulation in 3D blood vessel-on-chip</article-title><source>Biomedical Microdevices</source><volume>26</volume><elocation-id>2</elocation-id><pub-id pub-id-type="doi">10.1007/s10544-023-00684-w</pub-id><pub-id pub-id-type="pmid">38085384</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mikaty</surname><given-names>G</given-names></name><name><surname>Soyer</surname><given-names>M</given-names></name><name><surname>Mairey</surname><given-names>E</given-names></name><name><surname>Henry</surname><given-names>N</given-names></name><name><surname>Dyer</surname><given-names>D</given-names></name><name><surname>Forest</surname><given-names>KT</given-names></name><name><surname>Morand</surname><given-names>P</given-names></name><name><surname>Guadagnini</surname><given-names>S</given-names></name><name><surname>Prévost</surname><given-names>MC</given-names></name><name><surname>Nassif</surname><given-names>X</given-names></name><name><surname>Duménil</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Extracellular bacterial pathogen induces host cell surface reorganization to resist shear stress</article-title><source>PLOS Pathogens</source><volume>5</volume><elocation-id>e1000314</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1000314</pub-id><pub-id pub-id-type="pmid">19247442</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname><given-names>CJL</given-names></name><name><surname>Ikuta</surname><given-names>KS</given-names></name><name><surname>Sharara</surname><given-names>F</given-names></name><name><surname>Swetschinski</surname><given-names>L</given-names></name><name><surname>Robles Aguilar</surname><given-names>G</given-names></name><name><surname>Gray</surname><given-names>A</given-names></name><name><surname>Han</surname><given-names>C</given-names></name><name><surname>Bisignano</surname><given-names>C</given-names></name><name><surname>Rao</surname><given-names>P</given-names></name><name><surname>Wool</surname><given-names>E</given-names></name><name><surname>Johnson</surname><given-names>SC</given-names></name><name><surname>Browne</surname><given-names>AJ</given-names></name><name><surname>Chipeta</surname><given-names>MG</given-names></name><name><surname>Fell</surname><given-names>F</given-names></name><name><surname>Hackett</surname><given-names>S</given-names></name><name><surname>Haines-Woodhouse</surname><given-names>G</given-names></name><name><surname>Kashef Hamadani</surname><given-names>BH</given-names></name><name><surname>Kumaran</surname><given-names>EAP</given-names></name><name><surname>McManigal</surname><given-names>B</given-names></name><name><surname>Achalapong</surname><given-names>S</given-names></name><name><surname>Agarwal</surname><given-names>R</given-names></name><name><surname>Akech</surname><given-names>S</given-names></name><name><surname>Albertson</surname><given-names>S</given-names></name><name><surname>Amuasi</surname><given-names>J</given-names></name><name><surname>Andrews</surname><given-names>J</given-names></name><name><surname>Aravkin</surname><given-names>A</given-names></name><name><surname>Ashley</surname><given-names>E</given-names></name><name><surname>Babin</surname><given-names>FX</given-names></name><name><surname>Bailey</surname><given-names>F</given-names></name><name><surname>Baker</surname><given-names>S</given-names></name><name><surname>Basnyat</surname><given-names>B</given-names></name><name><surname>Bekker</surname><given-names>A</given-names></name><name><surname>Bender</surname><given-names>R</given-names></name><name><surname>Berkley</surname><given-names>JA</given-names></name><name><surname>Bethou</surname><given-names>A</given-names></name><name><surname>Bielicki</surname><given-names>J</given-names></name><name><surname>Boonkasidecha</surname><given-names>S</given-names></name><name><surname>Bukosia</surname><given-names>J</given-names></name><name><surname>Carvalheiro</surname><given-names>C</given-names></name><name><surname>Castañeda-Orjuela</surname><given-names>C</given-names></name><name><surname>Chansamouth</surname><given-names>V</given-names></name><name><surname>Chaurasia</surname><given-names>S</given-names></name><name><surname>Chiurchiù</surname><given-names>S</given-names></name><name><surname>Chowdhury</surname><given-names>F</given-names></name><name><surname>Clotaire Donatien</surname><given-names>R</given-names></name><name><surname>Cook</surname><given-names>AJ</given-names></name><name><surname>Cooper</surname><given-names>B</given-names></name><name><surname>Cressey</surname><given-names>TR</given-names></name><name><surname>Criollo-Mora</surname><given-names>E</given-names></name><name><surname>Cunningham</surname><given-names>M</given-names></name><name><surname>Darboe</surname><given-names>S</given-names></name><name><surname>Day</surname><given-names>NPJ</given-names></name><name><surname>De Luca</surname><given-names>M</given-names></name><name><surname>Dokova</surname><given-names>K</given-names></name><name><surname>Dramowski</surname><given-names>A</given-names></name><name><surname>Dunachie</surname><given-names>SJ</given-names></name><name><surname>Duong Bich</surname><given-names>T</given-names></name><name><surname>Eckmanns</surname><given-names>T</given-names></name><name><surname>Eibach</surname><given-names>D</given-names></name><name><surname>Emami</surname><given-names>A</given-names></name><name><surname>Feasey</surname><given-names>N</given-names></name><name><surname>Fisher-Pearson</surname><given-names>N</given-names></name><name><surname>Forrest</surname><given-names>K</given-names></name><name><surname>Garcia</surname><given-names>C</given-names></name><name><surname>Garrett</surname><given-names>D</given-names></name><name><surname>Gastmeier</surname><given-names>P</given-names></name><name><surname>Giref</surname><given-names>AZ</given-names></name><name><surname>Greer</surname><given-names>RC</given-names></name><name><surname>Gupta</surname><given-names>V</given-names></name><name><surname>Haller</surname><given-names>S</given-names></name><name><surname>Haselbeck</surname><given-names>A</given-names></name><name><surname>Hay</surname><given-names>SI</given-names></name><name><surname>Holm</surname><given-names>M</given-names></name><name><surname>Hopkins</surname><given-names>S</given-names></name><name><surname>Hsia</surname><given-names>Y</given-names></name><name><surname>Iregbu</surname><given-names>KC</given-names></name><name><surname>Jacobs</surname><given-names>J</given-names></name><name><surname>Jarovsky</surname><given-names>D</given-names></name><name><surname>Javanmardi</surname><given-names>F</given-names></name><name><surname>Jenney</surname><given-names>AWJ</given-names></name><name><surname>Khorana</surname><given-names>M</given-names></name><name><surname>Khusuwan</surname><given-names>S</given-names></name><name><surname>Kissoon</surname><given-names>N</given-names></name><name><surname>Kobeissi</surname><given-names>E</given-names></name><name><surname>Kostyanev</surname><given-names>T</given-names></name><name><surname>Krapp</surname><given-names>F</given-names></name><name><surname>Krumkamp</surname><given-names>R</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Kyu</surname><given-names>HH</given-names></name><name><surname>Lim</surname><given-names>C</given-names></name><name><surname>Lim</surname><given-names>K</given-names></name><name><surname>Limmathurotsakul</surname><given-names>D</given-names></name><name><surname>Loftus</surname><given-names>MJ</given-names></name><name><surname>Lunn</surname><given-names>M</given-names></name><name><surname>Ma</surname><given-names>J</given-names></name><name><surname>Manoharan</surname><given-names>A</given-names></name><name><surname>Marks</surname><given-names>F</given-names></name><name><surname>May</surname><given-names>J</given-names></name><name><surname>Mayxay</surname><given-names>M</given-names></name><name><surname>Mturi</surname><given-names>N</given-names></name><name><surname>Munera-Huertas</surname><given-names>T</given-names></name><name><surname>Musicha</surname><given-names>P</given-names></name><name><surname>Musila</surname><given-names>LA</given-names></name><name><surname>Mussi-Pinhata</surname><given-names>MM</given-names></name><name><surname>Naidu</surname><given-names>RN</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Nanavati</surname><given-names>R</given-names></name><name><surname>Nangia</surname><given-names>S</given-names></name><name><surname>Newton</surname><given-names>P</given-names></name><name><surname>Ngoun</surname><given-names>C</given-names></name><name><surname>Novotney</surname><given-names>A</given-names></name><name><surname>Nwakanma</surname><given-names>D</given-names></name><name><surname>Obiero</surname><given-names>CW</given-names></name><name><surname>Ochoa</surname><given-names>TJ</given-names></name><name><surname>Olivas-Martinez</surname><given-names>A</given-names></name><name><surname>Olliaro</surname><given-names>P</given-names></name><name><surname>Ooko</surname><given-names>E</given-names></name><name><surname>Ortiz-Brizuela</surname><given-names>E</given-names></name><name><surname>Ounchanum</surname><given-names>P</given-names></name><name><surname>Pak</surname><given-names>GD</given-names></name><name><surname>Paredes</surname><given-names>JL</given-names></name><name><surname>Peleg</surname><given-names>AY</given-names></name><name><surname>Perrone</surname><given-names>C</given-names></name><name><surname>Phe</surname><given-names>T</given-names></name><name><surname>Phommasone</surname><given-names>K</given-names></name><name><surname>Plakkal</surname><given-names>N</given-names></name><name><surname>Ponce-de-Leon</surname><given-names>A</given-names></name><name><surname>Raad</surname><given-names>M</given-names></name><name><surname>Ramdin</surname><given-names>T</given-names></name><name><surname>Rattanavong</surname><given-names>S</given-names></name><name><surname>Riddell</surname><given-names>A</given-names></name><name><surname>Roberts</surname><given-names>T</given-names></name><name><surname>Robotham</surname><given-names>JV</given-names></name><name><surname>Roca</surname><given-names>A</given-names></name><name><surname>Rosenthal</surname><given-names>VD</given-names></name><name><surname>Rudd</surname><given-names>KE</given-names></name><name><surname>Russell</surname><given-names>N</given-names></name><name><surname>Sader</surname><given-names>HS</given-names></name><name><surname>Saengchan</surname><given-names>W</given-names></name><name><surname>Schnall</surname><given-names>J</given-names></name><name><surname>Scott</surname><given-names>JAG</given-names></name><name><surname>Seekaew</surname><given-names>S</given-names></name><name><surname>Sharland</surname><given-names>M</given-names></name><name><surname>Shivamallappa</surname><given-names>M</given-names></name><name><surname>Sifuentes-Osornio</surname><given-names>J</given-names></name><name><surname>Simpson</surname><given-names>AJ</given-names></name><name><surname>Steenkeste</surname><given-names>N</given-names></name><name><surname>Stewardson</surname><given-names>AJ</given-names></name><name><surname>Stoeva</surname><given-names>T</given-names></name><name><surname>Tasak</surname><given-names>N</given-names></name><name><surname>Thaiprakong</surname><given-names>A</given-names></name><name><surname>Thwaites</surname><given-names>G</given-names></name><name><surname>Tigoi</surname><given-names>C</given-names></name><name><surname>Turner</surname><given-names>C</given-names></name><name><surname>Turner</surname><given-names>P</given-names></name><name><surname>van Doorn</surname><given-names>HR</given-names></name><name><surname>Velaphi</surname><given-names>S</given-names></name><name><surname>Vongpradith</surname><given-names>A</given-names></name><name><surname>Vongsouvath</surname><given-names>M</given-names></name><name><surname>Vu</surname><given-names>H</given-names></name><name><surname>Walsh</surname><given-names>T</given-names></name><name><surname>Walson</surname><given-names>JL</given-names></name><name><surname>Waner</surname><given-names>S</given-names></name><name><surname>Wangrangsimakul</surname><given-names>T</given-names></name><name><surname>Wannapinij</surname><given-names>P</given-names></name><name><surname>Wozniak</surname><given-names>T</given-names></name><name><surname>Young Sharma</surname><given-names>T</given-names></name><name><surname>Yu</surname><given-names>KC</given-names></name><name><surname>Zheng</surname><given-names>P</given-names></name><name><surname>Sartorius</surname><given-names>B</given-names></name><name><surname>Lopez</surname><given-names>AD</given-names></name><name><surname>Stergachis</surname><given-names>A</given-names></name><name><surname>Moore</surname><given-names>C</given-names></name><name><surname>Dolecek</surname><given-names>C</given-names></name><name><surname>Naghavi</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis</article-title><source>The Lancet</source><volume>399</volume><fpage>629</fpage><lpage>655</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(21)02724-0</pub-id><pub-id pub-id-type="pmid">35065702</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nejman</surname><given-names>D</given-names></name><name><surname>Livyatan</surname><given-names>I</given-names></name><name><surname>Fuks</surname><given-names>G</given-names></name><name><surname>Gavert</surname><given-names>N</given-names></name><name><surname>Zwang</surname><given-names>Y</given-names></name><name><surname>Geller</surname><given-names>LT</given-names></name><name><surname>Rotter-Maskowitz</surname><given-names>A</given-names></name><name><surname>Weiser</surname><given-names>R</given-names></name><name><surname>Mallel</surname><given-names>G</given-names></name><name><surname>Gigi</surname><given-names>E</given-names></name><name><surname>Meltser</surname><given-names>A</given-names></name><name><surname>Douglas</surname><given-names>GM</given-names></name><name><surname>Kamer</surname><given-names>I</given-names></name><name><surname>Gopalakrishnan</surname><given-names>V</given-names></name><name><surname>Dadosh</surname><given-names>T</given-names></name><name><surname>Levin-Zaidman</surname><given-names>S</given-names></name><name><surname>Avnet</surname><given-names>S</given-names></name><name><surname>Atlan</surname><given-names>T</given-names></name><name><surname>Cooper</surname><given-names>ZA</given-names></name><name><surname>Arora</surname><given-names>R</given-names></name><name><surname>Cogdill</surname><given-names>AP</given-names></name><name><surname>Khan</surname><given-names>MAW</given-names></name><name><surname>Ologun</surname><given-names>G</given-names></name><name><surname>Bussi</surname><given-names>Y</given-names></name><name><surname>Weinberger</surname><given-names>A</given-names></name><name><surname>Lotan-Pompan</surname><given-names>M</given-names></name><name><surname>Golani</surname><given-names>O</given-names></name><name><surname>Perry</surname><given-names>G</given-names></name><name><surname>Rokah</surname><given-names>M</given-names></name><name><surname>Bahar-Shany</surname><given-names>K</given-names></name><name><surname>Rozeman</surname><given-names>EA</given-names></name><name><surname>Blank</surname><given-names>CU</given-names></name><name><surname>Ronai</surname><given-names>A</given-names></name><name><surname>Shaoul</surname><given-names>R</given-names></name><name><surname>Amit</surname><given-names>A</given-names></name><name><surname>Dorfman</surname><given-names>T</given-names></name><name><surname>Kremer</surname><given-names>R</given-names></name><name><surname>Cohen</surname><given-names>ZR</given-names></name><name><surname>Harnof</surname><given-names>S</given-names></name><name><surname>Siegal</surname><given-names>T</given-names></name><name><surname>Yehuda-Shnaidman</surname><given-names>E</given-names></name><name><surname>Gal-Yam</surname><given-names>EN</given-names></name><name><surname>Shapira</surname><given-names>H</given-names></name><name><surname>Baldini</surname><given-names>N</given-names></name><name><surname>Langille</surname><given-names>MGI</given-names></name><name><surname>Ben-Nun</surname><given-names>A</given-names></name><name><surname>Kaufman</surname><given-names>B</given-names></name><name><surname>Nissan</surname><given-names>A</given-names></name><name><surname>Golan</surname><given-names>T</given-names></name><name><surname>Dadiani</surname><given-names>M</given-names></name><name><surname>Levanon</surname><given-names>K</given-names></name><name><surname>Bar</surname><given-names>J</given-names></name><name><surname>Yust-Katz</surname><given-names>S</given-names></name><name><surname>Barshack</surname><given-names>I</given-names></name><name><surname>Peeper</surname><given-names>DS</given-names></name><name><surname>Raz</surname><given-names>DJ</given-names></name><name><surname>Segal</surname><given-names>E</given-names></name><name><surname>Wargo</surname><given-names>JA</given-names></name><name><surname>Sandbank</surname><given-names>J</given-names></name><name><surname>Shental</surname><given-names>N</given-names></name><name><surname>Straussman</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The human tumor microbiome is composed of tumor type-specific intracellular bacteria</article-title><source>Science</source><volume>368</volume><fpage>973</fpage><lpage>980</lpage><pub-id pub-id-type="doi">10.1126/science.aay9189</pub-id><pub-id pub-id-type="pmid">32467386</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obino</surname><given-names>D</given-names></name><name><surname>Duménil</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The many faces of bacterium-endothelium interactions during systemic infections</article-title><source>Microbiology Spectrum</source><volume>7</volume><elocation-id>10</elocation-id><pub-id pub-id-type="doi">10.1128/microbiolspec.bai-0010-2019</pub-id><pub-id pub-id-type="pmid">30848239</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Connor</surname><given-names>C</given-names></name><name><surname>Brady</surname><given-names>E</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Moore</surname><given-names>E</given-names></name><name><surname>Stevens</surname><given-names>KR</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Engineering the multiscale complexity of vascular networks</article-title><source>Nature Reviews. Materials</source><volume>7</volume><fpage>702</fpage><lpage>716</lpage><pub-id pub-id-type="doi">10.1038/s41578-022-00447-8</pub-id><pub-id pub-id-type="pmid">35669037</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Offeddu</surname><given-names>GS</given-names></name><name><surname>Haase</surname><given-names>K</given-names></name><name><surname>Gillrie</surname><given-names>MR</given-names></name><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Morozova</surname><given-names>O</given-names></name><name><surname>Hickman</surname><given-names>D</given-names></name><name><surname>Knutson</surname><given-names>CG</given-names></name><name><surname>Kamm</surname><given-names>RD</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>An on-chip model of protein paracellular and transcellular permeability in the microcirculation</article-title><source>Biomaterials</source><volume>212</volume><fpage>115</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2019.05.022</pub-id><pub-id pub-id-type="pmid">31112823</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osinnski</surname><given-names>JN</given-names></name><name><surname>Ku</surname><given-names>DN</given-names></name><name><surname>Mukundan</surname><given-names>S</given-names></name><name><surname>Loth</surname><given-names>F</given-names></name><name><surname>Pettigrew</surname><given-names>RI</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Determination of wall shear stress in the aorta with the use of MR phase velocity mapping</article-title><source>Journal of Magnetic Resonance Imaging</source><volume>5</volume><fpage>640</fpage><lpage>647</lpage><pub-id pub-id-type="doi">10.1002/jmri.1880050605</pub-id><pub-id pub-id-type="pmid">8748480</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>Z</given-names></name><name><surname>Shu</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Endothelial response to pathophysiological stress</article-title><source>Arteriosclerosis, Thrombosis, and Vascular Biology</source><volume>39</volume><fpage>e233</fpage><lpage>e243</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.119.312580</pub-id><pub-id pub-id-type="pmid">31644356</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pries</surname><given-names>AR</given-names></name><name><surname>Secomb</surname><given-names>TW</given-names></name><name><surname>Gaehtgens</surname><given-names>P</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Design principles of vascular beds</article-title><source>Circulation Research</source><volume>77</volume><fpage>1017</fpage><lpage>1023</lpage><pub-id pub-id-type="doi">10.1161/01.res.77.5.1017</pub-id><pub-id pub-id-type="pmid">7554136</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahman</surname><given-names>MM</given-names></name><name><surname>Islam</surname><given-names>F</given-names></name><name><surname>-Or-Rashid</surname><given-names>MH</given-names></name><name><surname>Mamun</surname><given-names>AA</given-names></name><name><surname>Rahaman</surname><given-names>MS</given-names></name><name><surname>Islam</surname><given-names>MM</given-names></name><name><surname>Meem</surname><given-names>AFK</given-names></name><name><surname>Sutradhar</surname><given-names>PR</given-names></name><name><surname>Mitra</surname><given-names>S</given-names></name><name><surname>Mimi</surname><given-names>AA</given-names></name><name><surname>Emran</surname><given-names>TB</given-names></name><name><surname>Idroes</surname><given-names>R</given-names></name><name><surname>Tallei</surname><given-names>TE</given-names></name><name><surname>Ahmed</surname><given-names>M</given-names></name><name><surname>Cavalu</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The gut microbiota (Microbiome) in cardiovascular disease and its therapeutic regulation</article-title><source>Frontiers in Cellular and Infection Microbiology</source><volume>12</volume><elocation-id>903570</elocation-id><pub-id pub-id-type="doi">10.3389/fcimb.2022.903570</pub-id><pub-id pub-id-type="pmid">35795187</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rhodes</surname><given-names>KA</given-names></name><name><surname>Ma</surname><given-names>MC</given-names></name><name><surname>Rendón</surname><given-names>MA</given-names></name><name><surname>So</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Neisseria genes required for persistence identified via in vivo screening of a transposon mutant library</article-title><source>PLOS Pathogens</source><volume>18</volume><elocation-id>e1010497</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1010497</pub-id><pub-id pub-id-type="pmid">35580146</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossy</surname><given-names>T</given-names></name><name><surname>Distler</surname><given-names>T</given-names></name><name><surname>Meirelles</surname><given-names>LA</given-names></name><name><surname>Pezoldt</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Talà</surname><given-names>L</given-names></name><name><surname>Bouklas</surname><given-names>N</given-names></name><name><surname>Deplancke</surname><given-names>B</given-names></name><name><surname>Persat</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title><italic>Pseudomonas aeruginosa</italic> type IV pili actively induce mucus contraction to form biofilms in tissue-engineered human airways</article-title><source>PLOS Biology</source><volume>21</volume><elocation-id>e3002209</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.3002209</pub-id><pub-id pub-id-type="pmid">37527210</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rusniok</surname><given-names>C</given-names></name><name><surname>Vallenet</surname><given-names>D</given-names></name><name><surname>Floquet</surname><given-names>S</given-names></name><name><surname>Ewles</surname><given-names>H</given-names></name><name><surname>Mouzé-Soulama</surname><given-names>C</given-names></name><name><surname>Brown</surname><given-names>D</given-names></name><name><surname>Lajus</surname><given-names>A</given-names></name><name><surname>Buchrieser</surname><given-names>C</given-names></name><name><surname>Médigue</surname><given-names>C</given-names></name><name><surname>Glaser</surname><given-names>P</given-names></name><name><surname>Pelicic</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>NeMeSys: a biological resource for narrowing the gap between sequence and function in the human pathogen <italic>Neisseria meningitidis</italic></article-title><source>Genome Biology</source><volume>10</volume><elocation-id>R110</elocation-id><pub-id pub-id-type="doi">10.1186/gb-2009-10-10-r110</pub-id><pub-id pub-id-type="pmid">19818133</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarig-Nadir</surname><given-names>O</given-names></name><name><surname>Livnat</surname><given-names>N</given-names></name><name><surname>Zajdman</surname><given-names>R</given-names></name><name><surname>Shoham</surname><given-names>S</given-names></name><name><surname>Seliktar</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Laser photoablation of guidance microchannels into hydrogels directs cell growth in three dimensions</article-title><source>Biophysical Journal</source><volume>96</volume><fpage>4743</fpage><lpage>4752</lpage><pub-id pub-id-type="doi">10.1016/j.bpj.2009.03.019</pub-id><pub-id pub-id-type="pmid">19486697</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schubert-Unkmeir</surname><given-names>A</given-names></name><name><surname>Konrad</surname><given-names>C</given-names></name><name><surname>Slanina</surname><given-names>H</given-names></name><name><surname>Czapek</surname><given-names>F</given-names></name><name><surname>Hebling</surname><given-names>S</given-names></name><name><surname>Frosch</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title><italic>Neisseria meningitidis</italic> induces brain microvascular endothelial cell detachment from the matrix and cleavage of occludin: a role for MMP-8</article-title><source>PLOS Pathogens</source><volume>6</volume><elocation-id>e1000874</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1000874</pub-id><pub-id pub-id-type="pmid">20442866</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sotto</surname><given-names>MN</given-names></name><name><surname>Langer</surname><given-names>B</given-names></name><name><surname>Hoshino-Shimizu</surname><given-names>S</given-names></name><name><surname>de Brito</surname><given-names>T</given-names></name></person-group><year iso-8601-date="1976">1976</year><article-title>Pathogenesis of cutaneous lesions in acute meningococcemia in humans: light, immunofluorescent, and electron microscopic studies of skin biopsy specimens</article-title><source>The Journal of Infectious Diseases</source><volume>133</volume><fpage>506</fpage><lpage>514</lpage><pub-id pub-id-type="doi">10.1093/infdis/133.5.506</pub-id><pub-id pub-id-type="pmid">816975</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soyer</surname><given-names>M</given-names></name><name><surname>Charles-Orszag</surname><given-names>A</given-names></name><name><surname>Lagache</surname><given-names>T</given-names></name><name><surname>Machata</surname><given-names>S</given-names></name><name><surname>Imhaus</surname><given-names>A-F</given-names></name><name><surname>Dumont</surname><given-names>A</given-names></name><name><surname>Millien</surname><given-names>C</given-names></name><name><surname>Olivo-Marin</surname><given-names>J-C</given-names></name><name><surname>Duménil</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Early sequence of events triggered by the interaction of <italic>Neisseria meningitidis</italic> with endothelial cells</article-title><source>Cellular Microbiology</source><volume>16</volume><fpage>878</fpage><lpage>895</lpage><pub-id pub-id-type="doi">10.1111/cmi.12248</pub-id><pub-id pub-id-type="pmid">24320113</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urbaniak</surname><given-names>C</given-names></name><name><surname>Cummins</surname><given-names>J</given-names></name><name><surname>Brackstone</surname><given-names>M</given-names></name><name><surname>Macklaim</surname><given-names>JM</given-names></name><name><surname>Gloor</surname><given-names>GB</given-names></name><name><surname>Baban</surname><given-names>CK</given-names></name><name><surname>Scott</surname><given-names>L</given-names></name><name><surname>O’Hanlon</surname><given-names>DM</given-names></name><name><surname>Burton</surname><given-names>JP</given-names></name><name><surname>Francis</surname><given-names>KP</given-names></name><name><surname>Tangney</surname><given-names>M</given-names></name><name><surname>Reid</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Microbiota of human breast tissue</article-title><source>Applied and Environmental Microbiology</source><volume>80</volume><fpage>3007</fpage><lpage>3014</lpage><pub-id pub-id-type="doi">10.1128/AEM.00242-14</pub-id><pub-id pub-id-type="pmid">24610844</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varin</surname><given-names>A</given-names></name><name><surname>Mukhopadhyay</surname><given-names>S</given-names></name><name><surname>Herbein</surname><given-names>G</given-names></name><name><surname>Gordon</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Alternative activation of macrophages by IL-4 impairs phagocytosis of pathogens but potentiates microbial-induced signalling and cytokine secretion</article-title><source>Blood</source><volume>115</volume><fpage>353</fpage><lpage>362</lpage><pub-id pub-id-type="doi">10.1182/blood-2009-08-236711</pub-id><pub-id pub-id-type="pmid">19880493</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villwock</surname><given-names>A</given-names></name><name><surname>Schmitt</surname><given-names>C</given-names></name><name><surname>Schielke</surname><given-names>S</given-names></name><name><surname>Frosch</surname><given-names>M</given-names></name><name><surname>Kurzai</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Recognition via the class A scavenger receptor modulates cytokine secretion by human dendritic cells after contact with <italic>Neisseria meningitidis</italic></article-title><source>Microbes and Infection</source><volume>10</volume><fpage>1158</fpage><lpage>1165</lpage><pub-id pub-id-type="doi">10.1016/j.micinf.2008.06.009</pub-id><pub-id pub-id-type="pmid">18640287</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Gao</surname><given-names>H</given-names></name><name><surname>Lv</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>N</given-names></name><name><surname>Lin</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A comparative study unraveling the effects of TNF-α stimulation on endothelial cells between 2D and 3D culture</article-title><source>Biomedical Materials</source><volume>15</volume><elocation-id>065018</elocation-id><pub-id pub-id-type="doi">10.1088/1748-605X/ab95e3</pub-id><pub-id pub-id-type="pmid">32442992</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Welker</surname><given-names>A</given-names></name><name><surname>Cronenberg</surname><given-names>T</given-names></name><name><surname>Zöllner</surname><given-names>R</given-names></name><name><surname>Meel</surname><given-names>C</given-names></name><name><surname>Siewering</surname><given-names>K</given-names></name><name><surname>Bender</surname><given-names>N</given-names></name><name><surname>Hennes</surname><given-names>M</given-names></name><name><surname>Oldewurtel</surname><given-names>ER</given-names></name><name><surname>Maier</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Molecular motors govern liquidlike ordering and fusion dynamics of bacterial colonies</article-title><source>Physical Review Letters</source><volume>121</volume><elocation-id>118102</elocation-id><pub-id pub-id-type="doi">10.1103/PhysRevLett.121.118102</pub-id><pub-id pub-id-type="pmid">30265121</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>JNG</given-names></name></person-group><year iso-8601-date="2025">2025</year><data-title>PhotoAblationVessel2025</data-title><version designator="swh:1:rev:deade89040bda36e819491d1f4fe8cd83ffd027b">swh:1:rev:deade89040bda36e819491d1f4fe8cd83ffd027b</version><source>Software Heritage</source><ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:e0e084ca5909e31e1f37748360867b8bf33bb970;origin=https://gitlab.pasteur.fr/wong/photoablationvessel2025;visit=swh:1:snp:87d4294d599ea28742da459622a31bc7832c716e;anchor=swh:1:rev:deade89040bda36e819491d1f4fe8cd83ffd027b">https://archive.softwareheritage.org/swh:1:dir:e0e084ca5909e31e1f37748360867b8bf33bb970;origin=https://gitlab.pasteur.fr/wong/photoablationvessel2025;visit=swh:1:snp:87d4294d599ea28742da459622a31bc7832c716e;anchor=swh:1:rev:deade89040bda36e819491d1f4fe8cd83ffd027b</ext-link></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Nizamoglu</surname><given-names>M</given-names></name><name><surname>Kaper</surname><given-names>HJ</given-names></name><name><surname>Brouwer</surname><given-names>LA</given-names></name><name><surname>Borghuis</surname><given-names>T</given-names></name><name><surname>Burgess</surname><given-names>JK</given-names></name><name><surname>Harmsen</surname><given-names>MC</given-names></name><name><surname>Sharma</surname><given-names>PK</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Fibroblast alignment and matrix remodeling induced by a stiffness gradient in a skin-derived extracellular matrix hydrogel</article-title><source>Acta Biomaterialia</source><volume>182</volume><fpage>67</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1016/j.actbio.2024.05.018</pub-id><pub-id pub-id-type="pmid">38750915</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>HL</given-names></name><name><surname>Jiang</surname><given-names>XZ</given-names></name><name><surname>Ventikos</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2023">2023a</year><article-title>Role of blood flow in endothelial functionality: a review</article-title><source>Frontiers in Cell and Developmental Biology</source><volume>11</volume><elocation-id>1259280</elocation-id><pub-id pub-id-type="doi">10.3389/fcell.2023.1259280</pub-id><pub-id pub-id-type="pmid">37905167</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>M</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>Z</given-names></name><name><surname>Gao</surname><given-names>L</given-names></name><name><surname>Jian</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2023">2023b</year><article-title>Wall shear stress and its role in atherosclerosis</article-title><source>Frontiers in Cardiovascular Medicine</source><volume>10</volume><elocation-id>1083547</elocation-id><pub-id pub-id-type="doi">10.3389/fcvm.2023.1083547</pub-id><pub-id pub-id-type="pmid">37077735</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ziveri</surname><given-names>J</given-names></name><name><surname>Le Guennec</surname><given-names>L</given-names></name><name><surname>Dos Santos Souza</surname><given-names>I</given-names></name><name><surname>Barnier</surname><given-names>J-P</given-names></name><name><surname>Walter</surname><given-names>SM</given-names></name><name><surname>Diallo</surname><given-names>Y</given-names></name><name><surname>Smail</surname><given-names>Y</given-names></name><name><surname>Le Seac’h</surname><given-names>E</given-names></name><name><surname>Bouzinba-Segard</surname><given-names>H</given-names></name><name><surname>Faure</surname><given-names>C</given-names></name><name><surname>Morand</surname><given-names>PC</given-names></name><name><surname>Carel</surname><given-names>I</given-names></name><name><surname>Perriere</surname><given-names>N</given-names></name><name><surname>Schmitt</surname><given-names>T</given-names></name><name><surname>Izac</surname><given-names>B</given-names></name><name><surname>Letourneur</surname><given-names>F</given-names></name><name><surname>Coureuil</surname><given-names>M</given-names></name><name><surname>Rattei</surname><given-names>T</given-names></name><name><surname>Nassif</surname><given-names>X</given-names></name><name><surname>Bourdoulous</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Angiopoietin-like 4 protects against endothelial dysfunction during bacterial sepsis</article-title><source>Nature Microbiology</source><volume>9</volume><fpage>2434</fpage><lpage>2447</lpage><pub-id pub-id-type="doi">10.1038/s41564-024-01760-4</pub-id><pub-id pub-id-type="pmid">39103571</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.107813.3.sa0</article-id><title-group><article-title>eLife Assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Miao</surname><given-names>Edward A</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>Duke University</institution><country>United States</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Compelling</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Important</kwd></kwd-group></front-stub><body><p>The authors develop an <bold>important</bold> microfluidic microvascular model called &quot;Vessel-on-Chip&quot;, which they use to study <italic>Neisseria meningitidis</italic> interactions within this in vitro vascular system. <bold>Compelling</bold> evidence shows that the fabricated channels are lined by endothelial cells, and these can be colonized by N. meningitidis that in turn triggers neutrophil recruitment. This model has advantages over the human skin xenograft mouse model, which requires complex surgical techniques, however, it also carries limitations in that only endothelial cells and supplied specific immune cells in the microfluidics are present, while true vasculature contains a number of other cell types including smooth muscle cells, pericytes, and components of the immune system.</p><p>[Editors' note: this paper was reviewed by <ext-link ext-link-type="uri" xlink:href="https://www.reviewcommons.org/">Review Commons</ext-link>.]</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.107813.3.sa1</article-id><title-group><article-title>Reviewer #1 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>The work by Pinon et al describes the generation of a microvascular model to study <italic>Neisseria meningitidis</italic> interactions with blood vessels. The model uses a novel and relatively high throughput fabrication method that allows full control over the geometry of the vessels. The model is well characterized from the vascular standpoint and shows improvements when exposed to flow. The authors show that Neisseria binds to the 3D model in a similar geometry that in the animal xenograft model, induces an increase in permeability short after bacterial perfusion, and endothelial cytoskeleton rearrangements including a honeycomb actin structure. Finally, the authors show neutrophil recruitment to bacterial microcolonies and phagocytosis of Neisseria.</p><p>Strengths:</p><p>The article is overall well written, and it is a great advancement in the bioengineering and sepsis infection field. The authors achieved their aim at establishing a good model for Neisseria vascular pathogenesis and the results support the conclusions. I support the publication of the manuscript. I include below some clarifications that I consider would be good for readers.</p><p>One of the most novel things of the manuscript is the use of a relatively quick photoablation system. Could this technique be applied in other laboratories? While the revised manuscript includes more technical details as requested, the description remains difficult to follow for readers from a biology background. I recommend revising this section to improve clarity and accessibility for a broader scientific audience.</p><p>The authors suggest that in the animal model, early 3h infection with Neisseria do not show increase in vascular permeability, contrary to their findings in the 3D in vitro model. However, they show a non-significant increase in permeability of 70 KDa Dextran in the animal xenograft early infection. As a bioengineer this seems to point that if the experiment would have been done with a lower molecular weight tracer, significant increases in permeability could have been detected. I would suggest to do this experiment that could capture early events in vascular disruption.</p><p>One of the great advantages of the system is the possibility of visualizing infection-related events at high resolution. The authors show the formation of actin of a honeycomb structure beneath the bacterial microcolonies. This only occurred in 65% of the microcolonies. Is this result similar to in vitro 2D endothelial cultures in static and under flow? Also, the group has shown in the past positive staining of other cytoskeletal proteins, such as ezrin in the ERM complex. Does this also occur in the 3D system?</p><p>Significance:</p><p>The manuscript is comprehensive, complete and represents the first bioengineered model of sepsis. One of the major strengths is the carful characterization and benchmarking against the animal xenograft model. Beyond the technical achievement, the manuscript is also highly quantitative and includes advanced image analysis that could benefit many scientists. The authors show a quick photoablation method that would be useful for the bioengineering community and improved the state-of-the-art providing a new experimental model for sepsis.</p><p>My expertise is on infection bioengineered models.</p><p>Comments on revised version:</p><p>The authors have addressed all my concerns.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.107813.3.sa2</article-id><title-group><article-title>Reviewer #2 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Pinon and colleagues have developed a Vessel-on-Chip model showcasing geometrical and physical properties similar to the murine vessels used in the study of systemic infections. The authors succeed on their aim of developing an complex, humanized, in vitro model that can faithfully recapitulate the hallmarks of systemic infections.</p><p>The vessel was created via highly controllable laser photoablation in a collagen matrix, subsequent seeding of human endothelial cells, and flow perfusion to induce mechanical cues. This model could be infected with <italic>Neisseria meningitidis</italic> as a model of systemic infection. In this model, microcolony formation and dynamics, and effects on the host were very similar to those described for the human skin xenograft mouse model (the current gold standard for systemic studies) and were consistent with observations made in patients. The model could also recapitulate the neutrophil response upon N. meningitidis systemic infection.</p><p>The claims and the conclusions are supported by the data, the methods are properly presented, and the data is analyzed adequately. The most important strength of this manuscript is the technology developed to build this model, which is impressive and very innovative. The Vessel-on-Chip can be tuned to acquire complex shapes and, according to the authors, the process has been optimized to produce models very quickly. This is a great advancement compared with the technologies used to produce other equivalent models. This model proves to be equivalent to the most advanced model used to date (skin xenograft mouse model). The human skin xenograft mouse model requires complex surgical techniques and has the practical and ethical limitations associated with the use of animals. However, the Vessel-on-chip model is free of ethical concerns, can be produced quickly, and allows to precisely tune the vessel's geometry and to perform higher resolution microscopy. Both models were comparable in terms of the hallmarks defining the disease, suggesting that the presented model can be an effective replacement of the animal use in this area. In addition, the Vessel-on-Chip allows to perform microscopy with higher resolution and ease, which can in turn allow more complex and precise image-based analysis. The authors leverage the image-based analysis to obtain further insights into the infection, highlighting the capabilities of the model in this aspect.</p><p>A limitation of this model is that it lacks the multicellularity that characterizes other similar models, which could be useful to research disease more extensively. However, the authors discuss the possibilities of adding other cells to the model, for example, fibroblasts. The methodology would allow for integrating many different types of cells into the model, which would increase the scope of scientific questions that can be addressed. In addition, the technology presented in the current paper is also difficult to adapt for standard biology labs. The methodology is complex and requires specialized equipment and personnel, which might hinder its widespread utilization of this model by researchers in the field.</p><p>This manuscript will be of interest for a specialized audience focusing on the development of microphysiological models. The technology presented here can be of great interest to researchers whose main area of interest is the endothelium and the blood vessels, for example, researchers on the study of systemic infections, atherosclerosis, angiogenesis, etc. This manuscript can have great applications for a broad audience focusing on vasculature research. Due to the high degree of expertise required to produce these models, this paper can present an interesting opportunity to begin collaborations with researchers dealing with a wide range of diseases, including atherosclerosis, cancer (metastasis), and systemic infections of all kinds.</p></body></sub-article><sub-article article-type="referee-report" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.107813.3.sa3</article-id><title-group><article-title>Reviewer #3 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>In this manuscript Pinon et al. describe the development of a 3D model of human vasculature within a microchip to study <italic>Neisseria meningitidis</italic> (Nm)- host interactions and validate it through its comparison to the current gold-standard model consisting of human skin engrafted onto a mouse. There is a pressing need for robust biomimetic models with which to study Nm-host interactions because Nm is a human-specific pathogen for which research has been primarily limited to simple 2D human cell culture assays. Their investigation relies primarily on data derived from microscopy and its quantitative analysis, which support the authors' goal of validating their Vessel-on-Chip (VOC) as a useful tool for studying vascular infections by Nm, and by extension, other pathogens associated with blood vessels.</p><p>Strengths:</p><p>• Introduces a novel human in vitro system that promotes control of experimental variables and permits greater quantitative analysis than previous models</p><p>• The VOC model is validated by direct comparison to the state-of-the-art human skin graft on mouse model</p><p>• The authors make significant efforts to quantify, model, and statistically analyze their data</p><p>• The laser ablation approach permits defining custom vascular architecture</p><p>• The VOC model permits the addition and/or alteration of cell types and microbes added to the model</p><p>• The VOC model permits the establishment of an endothelium developed by shear stress and active infusion of reagents into the system</p><p>Weaknesses:</p><p>• The VOC model contains one cell type, human umbilical cord vascular endothelial cells (HUVECs), while true vasculature contains a number of other cell types that associate with and affect the endothelium, such as smooth muscle cells, pericytes, and components of the immune system. However, adding such complexity may be a future goal of this VOC model.</p><p>Impact:</p><p>The VOC model presented by Pinon et al. is an exciting advancement in the set of tools available to study human pathogens interacting with the vasculature. This manuscript focuses on validating the model, and as such sets the foundation for impactful research in the future. Of particular value is the photoablation technique that permits the custom design of vascular architecture without the use of artificial scaffolding structures described in previously published works.</p><p>Comments on revised version:</p><p>The authors have nicely addressed my (and other reviewers') comments.</p></body></sub-article><sub-article article-type="author-comment" id="sa4"><front-stub><article-id pub-id-type="doi">10.7554/eLife.107813.3.sa4</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Pinon</surname><given-names>Léa</given-names></name><role specific-use="author">Author</role><aff><institution>Institut Pasteur</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Chabaud</surname><given-names>Melanie</given-names></name><role specific-use="author">Author</role><aff><institution>Institut Pasteur</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Nivoit</surname><given-names>Pierre</given-names></name><role specific-use="author">Author</role><aff><institution>Institut Pasteur</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Wong Ng</surname><given-names>Jerome</given-names></name><role specific-use="author">Author</role><aff><institution>Institut Pasteur</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Nguyen</surname><given-names>Tri-Tho</given-names></name><role specific-use="author">Author</role><aff><institution>Institut Pasteur</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Paul</surname><given-names>Vanessa</given-names></name><role specific-use="author">Author</role><aff><institution>Institut Pasteur</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Bouquerel</surname><given-names>Charlotte</given-names></name><role specific-use="author">Author</role><aff><institution>Institut Pasteur</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Goussard</surname><given-names>Sylvie</given-names></name><role specific-use="author">Author</role><aff><institution>Institut Pasteur</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Smilovici</surname><given-names>Pauline</given-names></name><role specific-use="author">Author</role><aff><institution>Institut Pasteur</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Frachon</surname><given-names>Emmanuel</given-names></name><role specific-use="author">Author</role><aff><institution>Institut Pasteur</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Obino</surname><given-names>Dorian</given-names></name><role specific-use="author">Author</role><aff><institution>Institut Pasteur</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Gobaa</surname><given-names>Samy</given-names></name><role specific-use="author">Author</role><aff><institution>Institut Pasteur</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Dumenil</surname><given-names>Guilllaume</given-names></name><role specific-use="author">Author</role><aff><institution>Institut Pasteur</institution><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews</p><disp-quote content-type="editor-comment"><p><bold>Public Reviews:</bold></p><p><bold>Reviewer #1 (Public review):</bold></p><p>One of the most novel things of the manuscript is the use of a relatively quick photoablation system. Could this technique be applied in other laboratories? While the revised manuscript includes more technical details as requested, the description remains difficult to follow for readers from a biology background. I recommend revising this section to improve clarity and accessibility for a broader scientific audience.</p></disp-quote><p>As suggested, we have adapted the paragraph related to the photoablation technique in the Material &amp; Method section, starting line 1147. We believe it is now easier to follow.</p><disp-quote content-type="editor-comment"><p>The authors suggest that in the animal model, early 3h infection with Neisseria do not show increase in vascular permeability, contrary to their findings in the 3D in vitro model. However, they show a non-significant increase in permeability of 70 KDa Dextran in the animal xenograft early infection. As a bioengineer this seems to point that if the experiment would have been done with a lower molecular weight tracer, significant increases in permeability could have been detected. I would suggest to do this experiment that could capture early events in vascular disruption.</p></disp-quote><p>Comparing permeability under healthy and infected conditions using Dextran smaller than 70 kDa is challenging. Previous research (1) has shown that molecules below 70 kDa already diffuse freely in healthy tissue. Given this high baseline diffusion, we believe that no significant difference would be observed before and after <italic>N. meningitidis</italic> infection, and these experiments were not carried out. As discussed in the manuscript, bacteria-induced permeability in mice occurs at later time points, 16h post-infection, as shown previously (2). As discussed in the manuscript, this difference between the xenograft model and the chip could reflect the absence of various cell types present in the tissue parenchyma or simply vessel maturation time.</p><disp-quote content-type="editor-comment"><p>One of the great advantages of the system is the possibility of visualizing infection-related events at high resolution. The authors show the formation of actin in a honeycomb structure beneath the bacterial microcolonies. This only occurred in 65% of the microcolonies. Is this result similar to in vitro 2D endothelial cultures in static and under flow? Also, the group has shown in the past positive staining of other cytoskeletal proteins, such as ezrin, in the ERM complex. Does this also occur in the 3D system?</p></disp-quote><p>We imaged monolayers of endothelial cells in the flat regions of the chip (the two lateral channels) using the same microscopy conditions (i.e., Obj. 40X N.A. 1.05) that have been used to detect honeycomb structures in the 3D vessels in vitro. We showed that more than 56% of infected cells present these honeycomb structures in 2D, which is 13% less than in 3D, and is not significant due to the distributions of both populations. Thus, we conclude that under both in vitro conditions, 2D and 3D, the amount of infected cells exhibiting cortical plaques is similar. These results are in Figure 4E and S4B.</p><p>We also performed staining of ezrin in the chip and imaged both the 3D and 2D regions. Although ezrin staining was visible in 3D (Author response image 1), it was not as obvious as other markers under these infected conditions, and we did not include it in the main text. Interpretation of this result is not straightforward, as the substrate of the cells is different, and it would require further studies on the behavior of ERM proteins in these different contexts.</p><fig id="sa4fig1" position="float"><label>Author response image 1.</label><caption><title>F-actin (red) and ezrin (yellow) staining after 3h of infection with <italic>N. meningitidis</italic> (green) in 2D (top) and 3D (bottom) vessel-on-chip models.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107813-sa4-fig1-v1.tif"/></fig><disp-quote content-type="editor-comment"><p><bold>Recommendation to the authors:</bold></p><p><bold>Reviewer #1 (Recommendation to the authors):</bold></p><p>I appreciate that the authors addressed most of my comments, of special relevance are the change of the title and references to infection-on-chip. I think that the current choice of words better acknowledges the incipient but strong bioengineering infection community. I also appreciate the inclusion of a limitation paragraph that better frames the current work and proposes future advancements.</p><p>The addition of more methodological details has improved the manuscript. Although as mentioned earlier the wording needs to be accessible for the biology community. I also appreciated the addition of the quantification of binding under the WSS gradient in the different geometries and shown in Fig 3H. However, the description of the figure and the legend is not clear. What does &quot;vessel&quot; mean on the graph and &quot;normalized histograms ...(blue)&quot; in the figure legend. Could the authors rephrase it?</p></disp-quote><p>In Figure 3F, we investigated whether <italic>Neisseria meningitidis</italic> exhibits preferential sites of infection. We hypothesized that, if bacteria preferentially adhered to specific regions, the local shear stress at these sites would differ from the overall distribution. To test this, we compared the shear stress at bacterial adhesion sites in the VoC (orange dots and curve) with the shear stress along the entire vascular edges (blue dots and curve). The high Spearman correlation indicates that there is no distinct shear stress value associated with bacterial adhesion. This suggests that bacteria can adhere across all regions, independently of local shear stress. To enhance clarity, the legend of Figure 3 and the related text have been rephrased in the revised manuscript (L289-314).</p><disp-quote content-type="editor-comment"><p>Line 415. Should reference to Fig S5B, not Fig 5B. Also, the titles in Supplementary Figure 4 and 5 are duplicated, and the description of the legend inf Fig S5 seems a bit off. A and B seem to be swapped.</p></disp-quote><p>Indeed, the reference to the right figure has been corrected. Also, the title of Figure S4 has been adapted to its contents, and the legend of Figure S5 has been corrected.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Recommendation to the authors):</bold></p><p>Minor comments to the authors:</p><p>Line 163 &quot;they formed&quot; instead of &quot;formed&quot;.</p><p>Line 212 &quot;two days&quot; instead of &quot;two day&quot;</p><p>Line 269 a space between two words is missing.</p></disp-quote><p>These three comments have been addressed in the revised manuscript.</p><disp-quote content-type="editor-comment"><p>In addition, I appreciate answering the comments, especially those requiring hypothesizing about including further cells. However, when discussing which other cells could be relevant for the model (lines 631 to 632) it would be beneficial to discuss not only the role of those cells but also how could they be included in the model. I think for the reader, inclusion of further cells could be seen as a challenge or limitation, and addressing these technical points in the discussion could be helpful.</p></disp-quote><p>We thank Reviewer #2 for the insightful suggestion. Indeed, the method of introducing cells into the VoC depends on their type. Fibroblasts and dendritic cells, which are resident tissue cells, should be embedded in the collagen gel before polymerization and UV carving. This requires careful optimization to preserve chip integrity, as these cells exert pulling forces while migrating within the collagen matrix. In contrast, T cells and macrophages should be introduced through the vessel lumen to mimic their circulation in vivo. Pericytes can be co-seeded with endothelial cells, as they have been shown to self-organize within a few hours post-seeding. These important informations are now included in the manuscript (L577-587).</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #3 (Recommendation to the authors):</bold></p><p>Suggestions and Recommendations</p><p>Some suggestions related to the VOC itself:</p><p>Figure 1, Fig S1, paragraph starting line 1071: More information would be helpful for the laser photoablation. For instance, is a non-standard UV laser needed? Which form of UV light is used? What is the frequency of laser pulsing? How many pulses/how long is needed to ablate the region of interest?</p></disp-quote><p>The photoablation process requires a focused UV-laser, with high frequency (10 kHz) to lower the carving time while providing the required intensity to degrade collagen gel. To carve a reproducible number of 30 µm-large vessels, we used a 2 µm-large laser beam at an energy of 10 mW and moved the stage (<italic>i.e.</italic>, sample) at a maximum speed of 1 mm/s. This information has been added to the related paragraph starting on line 1147 of the revised manuscript.</p><disp-quote content-type="editor-comment"><p>It is difficult to understand the geometry of the VOC. In Figure 1C, is the light coloration representing open space through which medium can flow, and the dark section the collagen? On a single chip, how many vessels are cut through the collagen? It looks as if at least two are cut in Figure 1C in the righthand photo.</p></disp-quote><p>In Figure 1C, the light coloration is the Factin staining. The horizontal upper and lower parts are the 2D lateral channels that also contain endothelial cells, and are connected to inlets and outlets, respectively. In the middle, two vertically carved 3D vessels are shown in the confocal image.</p><p>Technically, we designed the PDMS structures to allow carving of 1 to 3 channels, maximizing the number of vessels that can be imaged while minimizing any loss of permeability at the PDMS/collagen/cells interface. This information has been added in the revised manuscript (L. 1147).</p><disp-quote content-type="editor-comment"><p>If multiple vessels are cut in the center channel between the lateral channels, how do you ensure that medium flow is even between all vessels? A single chip with multiple different vessel architectures through the center channel would be expected to have different hydrostatic resistance with different architectures, thereby causing differences in flow rates in each vessel.</p></disp-quote><p>To ensure a consistent flow rate regardless of the number of carved vessels, we opted to control the flow rate directly across the chip with a syringe pump. During experiments, one inlet and one outlet were closed, and a syringe pump was used. Because the carved vessels are arranged in parallel (derivation), the flow rate remains the same in each vessel. If a pressure controller had been used instead, the flow would have been distributed evenly across the different channels. This has been added to the revised manuscript in the paragraph starting on line 1210.</p><disp-quote content-type="editor-comment"><p>The figures imply that the laser ablation can be performed at depth within the collagen gel, rather than just etching the surface. If this is the case, it should be stated explicitly. If not, this needs to be clarified.</p></disp-quote><p>One of the main advantages of the photoablation technique is carving the collagen gel in volume, and not only etching the surface. Thanks to the 3D UV degradation, we can form the 3D architecture surrounded by the bulk collagen. This has been added to the revised manuscript, lines 154-155.</p><disp-quote content-type="editor-comment"><p>Is the in-vivo-like vessel architecture connected to the lateral channel at an oblique angle, or is the image turned to fit the entire structure? (Figure 1F and 3E). Is that why there is high shear stress at its junction with the lateral channel depicted in Figure 3E?</p></disp-quote><p>All structures require connection to the lateral channels to ensure media circulation and nutrient supply. The in vivo-like design must be rotated to allow the upper and lower branches of the complex structure to pass between the fixed PDMS pillars. To remain consistent with the image and the flow direction, we have kept the same orientation as in the COMSOL simulation. This leads to a locally higher shear stress at the top of the architecture. This has been added in the revised manuscript, in the paragraph starting on line 1474.</p><disp-quote content-type="editor-comment"><p>Figure S1F,G: In the legend, shapes are circles, not squares. On the graphs, what do the numbers in parentheses mean?</p></disp-quote><p>Indeed, the terms &quot;squares&quot; have been replaced by &quot;circles&quot; in Figure 1. (1) and (2) refer to the providers of the collagen, FujiFilm and Corning, respectively. We have added this mention in the legend in Figure S1.</p><disp-quote content-type="editor-comment"><p>Figure 3B: how do the images on the left and right differ? Each of the 4 images needs to be explained.</p></disp-quote><p>The four images represent the infected VoC from different viewing angles, illustrating the three-dimensional spread of infection throughout the vessel. A more detailed description has been added in the legend of Figure 3.</p><disp-quote content-type="editor-comment"><p>Figure S3C is not referenced but should be, likely before sentence starting on line 299.</p></disp-quote><p>Indeed, the reference to Figure S3C has been added line 301 of the revised manuscript.</p><disp-quote content-type="editor-comment"><p>Results in Figure 3 with the pilD mutant are very interesting. It is worth commenting in the Discussion about how T4P functionality in addition to the presence of T4P contributes to Nm infection, and how in the future this could be probed with pilT mutants.</p></disp-quote><p>We thank Reviewer #3 for this relevant insight. Following adhesion, a key functionality of <italic>Neisseria meningitidis</italic> for colony formation and enhanced infection is twitching motility. As suggested, we have added in the Discussion the idea of using a PilT mutant, which can adhere but cannot retract its pili, in the VoC model to investigate the role of motility in colonization in vitro under flow conditions (L611–623).</p><disp-quote content-type="editor-comment"><p>Which vessel design was used for the data presented in Figures 4, 5, and 6 and associated supplemental figures?</p></disp-quote><p>Straight channels have been mostly used in figures 4, 5, and 6. Rarely, we used the branched in vivo-like designs to observe potential similar infection patterns to in vivo, and related neutrophil activity. This has been added in the revised manuscript, lines 1435-1439.</p><disp-quote content-type="editor-comment"><p>Figure 4B-D: the images presented in Figure 4C are not representative of the averages presented in Figures 4B,D. For instance, the aggregates appear much larger and more elongated in the animal model in Figure 4C, but the animal model and VOC have the colony doubling time (implying same size) in Figure 4B, and same average aggregate elongation in Figure 4D.</p></disp-quote><p>The images in Figure 4C were selected to illustrate the elongation of colonies quantified in Figure 4D. The elongation angles are consistent between both images and align with the channel orientation. Representative images of colony expansion over time, corresponding to Figure 4A and 4B, are provided in Figure S4A.</p><disp-quote content-type="editor-comment"><p>Figures 4E-F: dextran does not appear to diffuse in the VOC in response to histamine in these images, yet there is a significant increase in histamine-induced permeability in Figure 4F. Dotted lines should be used to indicate vessel walls for histamine, and/or a more representative image should be selected. A control set of images should also be included for comparison.</p></disp-quote><p>We thank Reviewer #3 for the insightful comment. We confirm that we have carefully selected representative images for the histamine condition and adjusted them to display the same range of gray levels. The apparent increase in permeability with histamine is explained by a slight rise in background fluorescence, combined with the smaller channel size shown in Figure 4E.</p><disp-quote content-type="editor-comment"><p>Figure S4 title is a duplicate of Figure S5 and is unrelated to the content of Figure S4. Suggest rewording to mention changes in permeability induced by Nm infection in the VOC and animal model.</p></disp-quote><p>Indeed, the title of Figure S4 did not correspond to its content. We have, thus, changed it in the revised manuscript.</p><disp-quote content-type="editor-comment"><p>Line 489 &quot;...our Vessel-on-Chip model has the potential to fully capture the human neutrophil response during vascular infections, in a species-matched microenvironment&quot;, is an overstatement. As presented, the VOC model only contains endothelial cells and neutrophils. Many other cell types and structures can affect neutrophil activity. Thus, it is an overstatement to claim that the model can fully capture the human neutrophil response.</p></disp-quote><p>We agree with the Reviewer #3, that neutrophil activity is fully recapitulated with other cell types, such as platelets, pericytes, macrophages, dendritic cells, and fibroblasts, that secrete important molecules such as cytokines, chemokines, TNF-<italic>α</italic>, and histamine. In our simplified model we were able to reconstitute the complex interaction of neutrophils with endothelial cells and with bacteria. The text was modified accordingly.</p><disp-quote content-type="editor-comment"><p>Supplemental Figure 6 - Does CD62E staining overlap with sites of Nm attachment</p></disp-quote><p>E-selectin staining does not systematically colocalize with <italic>Neisseria meningitidis</italic> colonies although bacterial adhesion is required. Its overall induced expression is heterogeneous across the tissue and shows heterogeneity from cell to cell as seen in vivo.</p><disp-quote content-type="editor-comment"><p>Line 475, Figure 6E- Phagocytosis of Nm is described, but it is difficult to see. An arrow should be added to make this clear. Perhaps the reference should have been to Figure 6G? Consider changing the colors in Figure 6G away from red/green to be more color-blind friendly.</p></disp-quote><p>Indeed, the reference to the right figure is Figure 6G, where the phagocytosis event is zoomed in. We have changed it in the text. Adapting the color of this figure 6G would imply to also change all the color codes of the manuscript, as red has been used for actin and green for <italic>Neisseria meningitidis</italic>.</p><disp-quote content-type="editor-comment"><p>Lines 621-632 - This important discussion point should be reworked. Some suggested references to cite and discuss include PMID: 7913984, 15186399, 17991045, 18640287, 19880493.</p></disp-quote><p>We have introduced in the discussion parts the following references as suggested (3–7), and discussed more the importance of introducting of immune cells to study immune cell-bacteria interaction and related immune response (L659-678).</p><disp-quote content-type="editor-comment"><p>Minor corrections:</p><p>• Line 8 - suggest &quot;photoablation-generated&quot; instead of &quot;photoablation-based&quot;</p><p>• Line 57- remove the word &quot;either&quot;, or modify the sentence</p><p>• Sentence on lines 162-165 needs rewording</p><p>• Lines 204-205- &quot;loss of vascular permeability&quot; should read &quot;increase in vascular permeability&quot;</p><p>• Line 293- &quot;Measured&quot; shear stress, should be &quot;computed&quot;, since it was not directly measured (according to the Materials &amp; Methods)</p><p>• Line 304- &quot;consistently&quot; should be &quot;consistent&quot;</p><p>• Fig. 3 legend, second line: replace &quot;our&quot; with &quot;the VoC&quot;</p><p>• Line 371, change &quot;our&quot; to &quot;the&quot;</p><p>• Line 415- Figure 5B doesn’t appear to show 2-D data. Is this in Figure S5B? Some clarification is needed. The quantification of Nm vessel association in both the VOC and the animal model should be shown in Figure 5, for direct comparison.</p><p>• Supplementary Figure 5C: correlation coefficient with statistical significance should be calculated.</p><p>• Figure 6 title, rephrase to &quot;The infected VOC model&quot;</p><p>• Line 450, replace &quot;important&quot; with &quot;statistically significant&quot;</p><p>• Line 459, suggest rephrasing to &quot;bacterial pilus-mediated adhesion&quot;</p><p>• Line 533- grammar needs correction</p><p>• Line 589- should be &quot;sheds&quot;</p><p>• Line 1106- should be &quot;pellet&quot;</p><p>• Lines 1223-1224 - is the antibody solution introduced into the inlet of the VOC for staining? Please clarify.</p><p>• Line 1295-unclear why Figure 2B is being referenced here</p></disp-quote><p>All the suggested minor corrections have been taken into account in the revised manuscript.</p><p>References</p><p>(1) Gyohei Egawa, Satoshi Nakamizo, Yohei Natsuaki, Hiromi Doi, Yoshiki Miyachi, and Kenji Kabashima. Intravital analysis of vascular permeability in mice using two-photon microscopy. Scientific Reports, 3(1):1932, Jun 2013. ISSN 2045-2322. doi: 10.1038/srep01932.</p><p>(2) Valeria Manriquez, Pierre Nivoit, Tomas Urbina, Hebert Echenique-Rivera, Keira Melican, Marie-Paule Fernandez-Gerlinger, Patricia Flamant, Taliah Schmitt, Patrick Bruneval, Dorian Obino, and Guillaume Duménil. Colonization of dermal arterioles by <italic>Neisseria meningitidis</italic> provides a safe haven from neutrophils. Nature Communications, 12(1):4547, Jul 2021. ISSN 2041-1723. doi: 10.1038/s41467-021-24797-z.</p><p>(3) Katherine A. Rhodes, Man Cheong Ma, María A. Rendón, and Magdalene So. Neisseria genes required for persistence identified via in vivo screening of a transposon mutant library. PLOS Pathogens, 18(5):1–30, 05 2022. doi: 10.1371/journal.ppat.1010497.</p><p>(4) Heli Uronen-Hansson, Liana Steeghs, Jennifer Allen, Garth L. J. Dixon, Mohamed Osman, Peter Van Der Ley, Simon Y. C. Wong, Robin Callard, and Nigel Klein. Human dendritic cell activation by <italic>Neisseria meningitidis</italic>: phagocytosis depends on expression of lipooligosaccharide (los) by the bacteria and is required for optimal cytokine production. Cellular Microbiology, 6(7):625–637, 2004. doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1462-5822.2004.00387.x">https://doi.org/10.1111/j.1462-5822.2004.00387.x</ext-link>.</p><p>(5) M. C. Jacobsen, P. J. Dusart, K. Kotowicz, M. Bajaj-Elliott, S. L. Hart, N. J. Klein, and G. L. Dixon. A critical role for atf2 transcription factor in the regulation of e-selectin expression in response to non-endotoxin components of <italic>Neisseria meningitidis</italic>. Cellular Microbiology, 18(1):66–79, 2016. doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/cmi.12483">https://doi.org/10.1111/cmi.12483</ext-link>.</p><p>(6) Andrea Villwock, Corinna Schmitt, Stephanie Schielke, Matthias Frosch, and Oliver Kurzai. Recognition via the class a scavenger receptor modulates cytokine secretion by human dendritic cells after contact with <italic>Neisseria meningitidis</italic>. Microbes and Infection, 10(10):1158–1165, 2008. ISSN 1286-4579. doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.micinf.2008.06.009">https://doi.org/10.1016/j.micinf.2008.06.009</ext-link>.</p><p>(7) Audrey Varin, Subhankar Mukhopadhyay, Georges Herbein, and Siamon Gordon. Alternative activation of macrophages by il-4 impairs phagocytosis of pathogens but potentiates microbial-induced signalling and cytokine secretion. Blood, 115(2):353–362, Jan 2010. ISSN 0006-4971. doi: 10.1182/blood-2009-08-236711.</p></body></sub-article></article>